syndrome	score	normalized_score
BIRDSHOT CHORIORETINOPATHY	2.00826446	100.0
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.5	74.6913581291978
PITUITARY APOPLEXY	1.38049451	68.7406732278676
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.32072799	65.76464486156371
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.25549451	62.516393383767785
PERIPHERAL CONE DYSTROPHY	1.25196078	62.34043398845988
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	50.387029206302834
LOWRY-MACLEAN SYNDROME	1.00826446	50.20576124720147
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.00810718	50.19792960933044
EHLERS-DANLOS SYNDROME, TYPE I	1.00065189	49.826699119099096
MOWAT-WILSON SYNDROME; MOWS	1.00065189	49.826699119099096
MEVALONIC ACIDURIA; MEVA	1.00065189	49.826699119099096
TURCOT SYNDROME WITH POLYPOSIS	1.0	49.79423875279853
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	49.79423875279853
AMOEBIC KERATITIS	1.0	49.79423875279853
LEBER CONGENITAL AMAUROSIS 17	1.0	49.79423875279853
108450 ASYMMETRIC SHORT STATURE SYNDROME	1.0	49.79423875279853
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	1.0	49.79423875279853
CRANIOPHARYNGIOMA	0.81888388	40.775699431538015
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.77612146	38.64637728041057
MENINGIOMA	0.7079472	35.25169190117521
TSH-SECRETING PITUITARY ADENOMA	0.5947227	29.61376411550897
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.59301236	29.528599037200507
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.59131818	29.44423863379029
MUCOPOLYSACCHARIDOSIS TYPE 2	0.57164344	28.46454993283106
PERSISTENT PLACOID MACULOPATHY	0.5133333	25.561040899961952
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50840336	25.315558290564976
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50840336	25.315558290564976
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.50826446	25.30864187080222
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50826446	25.30864187080222
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.5070922	25.25027007648186
8Q24.3 MICRODELETION SYNDROME	0.50549451	25.1707143191689
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.50364964	25.07885042192103
AGEL AMYLOIDOSIS	0.50316456	25.05469623258682
INTERMEDIATE OSTEOPETROSIS	0.50316456	25.05469623258682
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.50065189	24.929579742699822
PELVIS-SHOULDER DYSPLASIA	0.5	24.897119376399264
RESTRICTIVE DERMOPATHY	0.5	24.897119376399264
RHYNS SYNDROME	0.5	24.897119376399264
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	24.897119376399264
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	24.897119376399264
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.5	24.897119376399264
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.5	24.897119376399264
PINEOCYTOMA	0.5	24.897119376399264
MATTHEW-WOOD SYNDROME	0.5	24.897119376399264
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.5	24.897119376399264
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.5	24.897119376399264
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	22.503166739304845
NELSON SYNDROME	0.4519231	22.503166739304845
JUVENILE GLAUCOMA	0.43124969999999996	21.473750523872738
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.3627448	18.06260117753615
LETHAL KNIEST-LIKE DYSPLASIA	0.3621556	18.033262412063003
LEBER HEREDITARY OPTIC NEUROPATHY	0.36013388	17.932592403691693
PSEUDOACHONDROPLASIA	0.3522009	17.537575703550516
NON-FUNCTIONING PITUITARY ADENOMA	0.34472270000000005	17.16520442730934
PROLACTINOMA	0.34472270000000005	17.16520442730934
ATELOSTEOGENESIS TYPE I	0.344322	17.145251875841094
HYPOCHONDROPLASIA	0.333333	16.59806298618659
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.333333	16.59806298618659
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.333333	16.59806298618659
HYPOCHONDROPLASIA	0.333333	16.59806298618659
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	16.59806298618659
KNIEST-LIKE DYSPLASIA, LETHAL	0.32202396000000005	16.034937948361645
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.31945799999999996	15.90716792349151
XQ21 MICRODELETION SYNDROME	0.31862747999999996	15.865812812322536
NEOVASCULAR GLAUCOMA	0.31382006	15.626430993057557
RETINAL CAPILLARY MALFORMATION	0.3108338	15.477732449639625
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28870529	14.375860139455938
OPTIC ATROPHY 1; OPA1	0.28870529	14.375860139455938
NARP SYNDROME	0.27795258999999994	13.840437628418718
POEMS SYNDROME	0.2777778	13.83173409342712
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.25865907	12.879731487156826
CATARACT 7; CTRCT7	0.25826446	12.860082182602584
RETINOSCHISIS OF FOVEA	0.25826446	12.860082182602584
OPTIC ATROPHY 9; OPA9	0.25745529	12.819790178430981
THANATOPHORIC DYSPLASIA, TYPE I	0.2570922	12.801710388282228
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.2570922	12.801710388282228
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.2560241	12.748525161870363
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	12.722154630969271
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	12.579598206901496
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.25	12.448559688199632
ATR-16 SYNDROME	0.25	12.448559688199632
SEVERE HEMOPHILIA A	0.25	12.448559688199632
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	12.448559688199632
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY;;NADPH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;;TPNH-METHEMOGLOBIN REDUCTASE DEFICIENCY	0.25	12.448559688199632
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.25	12.448559688199632
THANATOPHORIC DYSPLASIA, TYPE II	0.25	12.448559688199632
THANATOPHORIC DYSPLASIA TYPE 1	0.25	12.448559688199632
CONGENITAL FACTOR II DEFICIENCY	0.25	12.448559688199632
HEMOPHILIA B	0.25	12.448559688199632
RETINITIS PUNCTATA ALBESCENS	0.2366153	11.78207874076505
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.23376609999999998	11.640204995710574
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.229167	11.411196312262579
BOHRING-OPITZ SYNDROME	0.22287449	11.097865566968208
PITUITARY CARCINOMA	0.21382781	10.647393023128041
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.210989	10.506036640214209
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20943396	10.428604607184058
RETINITIS PIGMENTOSA 18	0.2083333	10.373798080358402
CRI-DU-CHAT SYNDROME	0.20561042000000002	10.238214343543182
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.20364964000000002	10.14057879608147
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20261267	10.08894366432198
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20065189	9.991308116860267
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20065189	9.991308116860267
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	9.958847750559706
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.2	9.958847750559706
ROMANO-WARD SYNDROME	0.2	9.958847750559706
TRANSALDOLASE DEFICIENCY	0.2	9.958847750559706
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	9.958847750559706
TRICHOTHIODYSTROPHY	0.2	9.958847750559706
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.958847750559706
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.2	9.958847750559706
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.19987778	9.95276189869934
%156230 MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE	0.1916667	9.54389742076101
INTESTINAL LYMPHANGIECTASIA	0.19014750000000002	9.468250013247758
LEBER CONGENITAL AMAUROSIS	0.1875	9.336419766149724
USHER SYNDROME TYPE 2	0.17493106000000003	8.710558966920125
RIFT VALLEY FEVER	0.17493106000000003	8.710558966920125
USHER SYNDROME TYPE 3	0.17493106000000003	8.710558966920125
USHER SYNDROME TYPE 1	0.17493106000000003	8.710558966920125
LANGER MESOMELIC DYSPLASIA	0.1737592	8.652207090295269
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.17226879999999997	8.577993756858097
PALLISTER-KILLIAN SYNDROME	0.166667	8.299056390212673
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.166667	8.299056390212673
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.166667	8.299056390212673
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	8.299056390212673
MESOMELIA-SYNOSTOSES SYNDROME	0.1607143	8.002646225188888
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.15384599999999998	7.660644455163042
GREENBERG DYSPLASIA	0.15384599999999998	7.660644455163042
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	7.531894479674254
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.14946139	7.442316137985134
EHLERS-DANLOS SYNDROME, TYPE VI	0.1488811	7.413421039179272
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.14835151	7.387050508278177
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.14835151	7.387050508278177
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.14761499999999997	7.350376553494353
DE BARSY SYNDROME	0.14350888999999997	7.1459159318091
WRINKLY SKIN SYNDROME	0.14350888999999997	7.1459159318091
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.14350888999999997	7.1459159318091
CLEIDOCRANIAL DYSPLASIA; CCD	0.14285699999999998	7.113455565508538
ATELOSTEOGENESIS TYPE II	0.14285699999999998	7.113455565508538
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	7.113455565508538
BOOMERANG DYSPLASIA	0.14285699999999998	7.113455565508538
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	7.113455565508538
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.14285699999999998	7.113455565508538
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	7.113455565508538
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.14285699999999998	7.113455565508538
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.14285699999999998	7.113455565508538
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.14285699999999998	7.113455565508538
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.14285699999999998	7.113455565508538
OMODYSPLASIA	0.14285699999999998	7.113455565508538
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.14285699999999998	7.113455565508538
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.14285699999999998	7.113455565508538
BRACHYDACTYLY, TYPE E	0.14285699999999998	7.113455565508538
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.13898518999999998	6.920661733963065
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.13443396	6.694036700724166
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.1310241	6.52424531777055
CONE-ROD DYSTROPHY 2	0.13071191	6.508700054374312
PINEOBLASTOMA	0.13049451	6.497874786869455
MEIER-GORLIN SYNDROME 1; MGORS1	0.12955470000000002	6.451077663347188
RETINITIS PIGMENTOSA 58	0.1291667	6.431757498711101
CONE-ROD DYSTROPHY 8; CORD8	0.1282464	6.385931860786902
7Q11.23 MICRODUPLICATION SYNDROME	0.12565189	6.256740210400377
ADENOHYPOPHYSITIS	0.125	6.224279844099816
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.125	6.224279844099816
NIEVERGELT SYNDROME	0.125	6.224279844099816
ODONTOCHONDRODYSPLASIA; ODCD	0.125	6.224279844099816
PANHYPOPHYSITIS	0.125	6.224279844099816
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.125	6.224279844099816
DYSCHONDROSTEOSIS AND NEPHRITIS	0.125	6.224279844099816
SHEEHAN SYNDROME	0.125	6.224279844099816
BARATELA-SCOTT SYNDROME	0.1212454	6.037322395278558
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.11776726000000003	5.864131061702901
DOWN SYNDROME	0.11190470000000001	5.5722093493602936
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.11176288999999999	5.565148028362758
PANHYPOPITUITARISM	0.11111099999999999	5.532687662062196
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.11111099999999999	5.532687662062196
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.11111099999999999	5.532687662062196
PITUITARY DWARFISM IV	0.11111099999999999	5.532687662062196
PANHYPOPITUITARISM, X-LINKED	0.11111099999999999	5.532687662062196
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11111099999999999	5.532687662062196
OPTIC ATROPHY 5; OPA5	0.11013388	5.484032715492063
BEHÇET DISEASE	0.10838817	5.397106414958914
RHEUMATOID ARTHRITIS	0.1073729	5.346551818180361
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10714280000000001	5.335094163843342
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.10667599000000001	5.311849715251149
SHORT SYNDROME	0.10633490000000001	5.294865398354957
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.10526179000000001	5.241430702806941
MYCETOMA	0.1046099	5.208970336506378
ESOPHAGEAL ATRESIA	0.10364964	5.161154920801616
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.10269338	5.113538682051865
HENNEKAM-BEEMER SYNDROME	0.10261267	5.1095197890421264
ALPHA-THALASSEMIA	0.10236407	5.097140941288181
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.10236407	5.097140941288181
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	4.979423875279853
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	4.979423875279853
DRACUNCULIASIS	0.1	4.979423875279853
ACQUIRED ICHTHYOSIS	0.1	4.979423875279853
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	4.93827192460499
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	4.861006204332273
BETA-THALASSEMIA MAJOR	0.09586976	4.7737617186134935
NOCARDIOSIS	0.09408600000000002	4.684940747295803
SARCOSINEMIA	0.09286988	4.624384977663749
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.09286988	4.624384977663749
VON HIPPEL-LINDAU DISEASE	0.09159776000000001	4.5610407306615395
STURGE-WEBER SYNDROME	0.09131818000000001	4.5471192573910315
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	4.526749430202036
JOUBERT SYNDROME 5	0.0909091	4.526749430202036
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	4.526749430202036
AICA-RIBOSIDURIA	0.0909091	4.526749430202036
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	4.526749430202036
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.09078859000000002	4.520748726489938
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.09078859	4.520748726489937
SALT-AND-PEPPER SYNDROME	0.08831784000000001	4.39771961109146
12Q14 MICRODELETION SYNDROME	0.08827089	4.395381771582016
PETERS-PLUS SYNDROME; PTRPLS	0.0879121	4.3775160966599
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.08605905999999999	4.285245380481413
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.08596490000000001	4.28055675496045
MELAS	0.08594597000000001	4.27961415002086
CAMPOMELIC DYSPLASIA	0.08553459999999999	4.25913029402512
MYHRE SYNDROME	0.08466719000000002	4.215938273388557
PLACENTAL INSUFFICIENCY	0.0834783	4.1567384008777415
RETINAL CONE DYSTROPHY 3B	0.08333330000000001	4.1495182362585865
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	4.1495182362585865
BULLOUS IMPETIGO	0.08333330000000001	4.1495182362585865
GANGLIOCYTOMA	0.08333330000000001	4.1495182362585865
FAMILIAL MELANOMA	0.08333330000000001	4.1495182362585865
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.08333330000000001	4.1495182362585865
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	4.1495182362585865
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.08333330000000001	4.1495182362585865
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.08333330000000001	4.1495182362585865
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	4.1495182362585865
CITRULLINEMIA TYPE I	0.08333330000000001	4.1495182362585865
SLC35A2-CDG	0.08297595	4.131724265040273
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	4.103922149775036
FAMILIAL THROMBOCYTOSIS	0.08040457000000001	4.003684355396102
CONE-ROD DYSTROPHY 10	0.0803653	4.001728935640279
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.08006537000000001	3.986794149611153
ACHONDROPLASIA	0.0776557	3.8668064663156962
MEIER-GORLIN SYNDROME 2; MGORS2	0.07692310000000001	3.830327207005397
NEUROTROPHIC KERATOPATHY	0.07692310000000001	3.830327207005397
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	3.830327207005397
MEHMO SYNDROME; MEHMO	0.07692310000000001	3.830327207005397
MEIER-GORLIN SYNDROME 3; MGORS3	0.07692310000000001	3.830327207005397
MEIER-GORLIN SYNDROME 5; MGORS5	0.07692310000000001	3.830327207005397
ULBRIGHT-HODES SYNDROME	0.07692310000000001	3.830327207005397
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.07692310000000001	3.830327207005397
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	3.776061445612596
BETA-THALASSEMIA	0.07379267	3.6744498281864733
HEMOGLOBIN C-BETA-THALASSEMIA SYNDROME	0.07379267	3.6744498281864733
DOMINANT BETA-THALASSEMIA	0.07379267	3.6744498281864733
BETA-THALASSEMIA ASSOCIATED WITH ANOTHER HEMOGLOBIN ANOMALY	0.07379267	3.6744498281864733
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.07379267	3.6744498281864733
HB BART'S HYDROPS FETALIS	0.07379267	3.6744498281864733
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.07375889999999999	3.67276827674379
CRYPTOCOCCOSIS	0.0723324	3.601736795162924
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	3.593212519430832
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.07208049000000001	3.589193128478707
DELTA-BETA-THALASSEMIA	0.07142860000000001	3.556732762178145
PRIMARY FAMILIAL POLYCYTHEMIA	0.07142860000000001	3.556732762178145
PEARSON SYNDROME	0.07142860000000001	3.556732762178145
HEMOGLOBIN E-BETA-THALASSEMIA SYNDROME	0.07142860000000001	3.556732762178145
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.07048488	3.509740943182354
HERMANSKY-PUDLAK SYNDROME	0.0688889	3.4302703340176626
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	3.4121053957206415
KEUTEL SYNDROME; KTLS	0.0684783	3.4098248195857632
AMYLOIDOSIS	0.0682681	3.399358070599925
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.06731859	3.352077942961755
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.06701268	3.3368453873848867
191400 ULNA AND FIBULA, HYPOPLASIA OF;;MESOMELIC DWARFISM OF HYPOPLASTIC ULNA AND FIBULA TYPE;;REINHARDT-PFEIFFER MESOMELIC DYSPLASIA	0.0666667	3.3196175766611935
DIASTROPHIC DWARFISM	0.0666667	3.3196175766611935
ELLIS-VAN CREVELD SYNDROME	0.0666667	3.3196175766611935
RETINITIS PIGMENTOSA 75; RP75	0.0666667	3.3196175766611935
ELLIS VAN CREVELD SYNDROME	0.0666667	3.3196175766611935
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0666667	3.3196175766611935
RETINITIS PIGMENTOSA 41	0.0666667	3.3196175766611935
MALIGNANT ATROPHIC PAPULOSIS	0.0663083	3.30177132149219
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.06618413000000001	3.295588370866256
RETINITIS PIGMENTOSA 20	0.06566456	3.2697167782374637
WERNER SYNDROME	0.06540679	3.2568813173141553
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.06509334	3.2412733131770906
FASCIAL DYSTROPHY, CONGENITAL	0.0647549	3.2244209510135935
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.06446078	3.20977546951162
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	3.2023471649744777
MYELOPEROXIDASE DEFICIENCY	0.0638946	3.1815829674145606
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.06382006	3.1778713048579275
ALAND ISLAND EYE DISEASE	0.0625	3.112139922049908
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	3.112139922049908
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	3.112139922049908
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	3.112139922049908
MACULAR CORNEAL DYSTROPHY	0.0625	3.112139922049908
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.062346200000000004	3.1044815681297275
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06168685	3.0716497368080695
EMANUEL SYNDROME	0.06103496	3.0391893705075077
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	3.0391893705075077
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	3.0391893705075077
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.05998189	2.9867525515040985
HYPOPLASMINOGENEMIA	0.0596073	2.9681001276096874
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0594828	2.961900744884964
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.0592934	2.9524697160651843
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.05872016	2.9239256666425297
OCULOCUTANEOUS ALBINISM TYPE 4	0.05872016	2.9239256666425297
OCULOCUTANEOUS ALBINISM TYPE 2	0.05872016	2.9239256666425297
OCULOCUTANEOUS ALBINISM TYPE 1B	0.05872016	2.9239256666425297
OCULOCUTANEOUS ALBINISM TYPE 1A	0.05872016	2.9239256666425297
SICKLE CELL ANEMIA	0.0583717	2.9065743662067294
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.889117004042386
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.0573294	2.854673831154688
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0573294	2.854673831154688
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0571769	2.847080209744886
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.05667425	2.822051135635792
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.056207490000000006	2.798809176755536
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.05602236	2.78959076933523
MICROSPORIDIOSIS	0.05588346	2.782674349572466
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.055555600000000004	2.766348810454974
VACTERL WITH HYDROCEPHALUS	0.055555600000000004	2.766348810454974
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.055555600000000004	2.766348810454974
FRIED SYNDROME	0.055555600000000004	2.766348810454974
PRIMARY CILIARY DYSKINESIA	0.055383100000000005	2.7577593042701163
MECKEL SYNDROME, TYPE 1; MKS1	0.05499567	2.7384675223501196
MUCOPOLYSACCHARIDOSIS, TYPE II	0.054694370000000006	2.7234645182139015
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0546099	2.7192583988664523
YELLOW FEVER	0.054231	2.700391361803017
LASSA FEVER	0.054231	2.700391361803017
VIRAL HEMORRHAGIC FEVER	0.054231	2.700391361803017
1P36 DELETION SYNDROME	0.05339623	2.6588246251193435
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.05328349	2.653210822642353
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	2.6207504563417907
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0526316	2.6207504563417907
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	2.6207504563417907
15Q OVERGROWTH SYNDROME	0.0526316	2.6207504563417907
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0526316	2.6207504563417907
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.052403889999999995	2.609411810235391
CONGENITAL ANALBUMINEMIA	0.05188166	2.583407764931517
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.05188166	2.583407764931517
JUVENILE XANTHOGRANULOMA	0.051742760000000006	2.576491345168754
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.051268640000000004	2.552882900691277
MOHR-TRANEBJAERG SYNDROME	0.0509092	2.534984859513971
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0502451	2.501916505558237
PAGOD SYNDROME	0.050231670000000006	2.5012477689317874
HOLOPROSENCEPHALY	0.049579780000000004	2.468787402631225
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.049189430000000006	2.4493502215340706
NOONAN SYNDROME	0.048270890000000004	2.403612221470075
FEINGOLD SYNDROME	0.048270890000000004	2.403612221470075
ALSTROM SYNDROME; ALMS	0.04812185	2.3961908881263576
MEACHAM SYNDROME	0.047619	2.371151855169513
CEROID STORAGE DISEASE	0.047619	2.371151855169513
CEPHALIN LIPIDOSIS	0.047619	2.371151855169513
DEXTROCARDIA	0.047619	2.371151855169513
KAPOSI SARCOMA	0.047619	2.371151855169513
BURKITT LYMPHOMA	0.047619	2.371151855169513
ACROCEPHALOSYNDACTYLY	0.047619	2.371151855169513
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	2.371151855169513
TUFTSIN DEFICIENCY	0.047619	2.371151855169513
CHARGE SYNDROME	0.04731307	2.355918303707869
NEUROFIBROMATOSIS TYPE 1	0.04729475	2.3550060732539184
WEILL-MARCHESANI SYNDROME 1; WMS1	0.04667599	2.324195390083237
DYSOSTEOSCLEROSIS	0.04644638	2.3127621349232066
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0462766	2.3043080690677566
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0460241	2.2917350237826746
NEONATAL LUPUS ERYTHEMATOSUS	0.04584237000000001	2.282685916774129
ACHONDROGENESIS TYPE 1B	0.0455537	2.2683118138733582
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.045352289999999996	2.258282756246157
CONGENITAL DISORDER OF GLYCOSYLATION	0.0447004	2.2258223899455953
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.04413019000000001	2.1974292170663623
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04413019000000001	2.1974292170663623
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04413019000000001	2.1974292170663623
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.04411766	2.19680529525479
OPTIC PATHWAY GLIOMA	0.04370848000000001	2.1764304886419197
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0435606	2.1690669166151553
PREPAPILLARY VASCULAR LOOPS	0.0435606	2.1690669166151553
USHER SYNDROME	0.0435322	2.167652760234576
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	2.1649688507658005
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	2.1649688507658005
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	2.1649688507658005
HYDATIDIFORM MOLE	0.043478300000000004	2.1649688507658005
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	2.1649688507658005
LICHTENSTEIN SYNDROME	0.043478300000000004	2.1649688507658005
HYDROXYKYNURENINURIA	0.043478300000000004	2.1649688507658005
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	2.1649688507658005
ASHERMAN SYNDROME	0.043478300000000004	2.1649688507658005
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	2.1649688507658005
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	2.1649688507658005
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	2.1649688507658005
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.1649688507658005
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	2.1649688507658005
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	2.1649688507658005
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.043478300000000004	2.1649688507658005
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	2.1649688507658005
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	2.1649688507658005
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	2.1649688507658005
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.043478300000000004	2.1649688507658005
HALLERMANN-STREIFF SYNDROME	0.04316456	2.149346406299497
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.04316456	2.149346406299497
YUNIS-VARON SYNDROME	0.04288616	2.1354836902307177
INFANTILE MYOFIBROMATOSIS	0.0421099	2.0968304144564702
COACH SYNDROME	0.04172801	2.0778144926191646
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.0414764	2.0652857642065725
OPTIC ATROPHY 8	0.04147524	2.0652280028896195
GYRATE ATROPHY OF CHOROID AND RETINA	0.0409993	2.041528932897613
MUCOLIPIDOSIS IV; ML4	0.04083964	2.0335787847383413
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.040825570000000005	2.032878179799089
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.04069875	2.0265632744404587
CHST3-RELATED SKELETAL DYSPLASIA	0.0404008	2.0117270810040626
KNIEST DYSPLASIA	0.0404008	2.0117270810040626
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.04	1.991769550111941
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.04	1.991769550111941
HALLERMANN-STREIFF SYNDROME; HSS	0.04	1.991769550111941
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.04	1.991769550111941
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.04	1.991769550111941
SECKEL SYNDROME 1; SCKL1	0.04	1.991769550111941
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.04	1.991769550111941
SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES	0.04	1.991769550111941
CENTRAL PRECOCIOUS PUBERTY	0.04	1.991769550111941
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.04	1.991769550111941
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.04	1.991769550111941
DERMOTRICHIC SYNDROME	0.04	1.991769550111941
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.04	1.991769550111941
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.04	1.991769550111941
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.04	1.991769550111941
TRANSKETOLASE DEFICIENCY	0.04	1.991769550111941
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.9768910315726047
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.03936394000000001	1.9600974266108364
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.039113390000000005	1.9476214800913227
RHOMBENCEPHALOSYNAPSIS	0.038856299999999996	1.934819879250365
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.03870529	1.9273004512563054
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0384615	1.9151611137907607
PHOCOMELIA, SCHINZEL TYPE	0.0384615	1.9151611137907607
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.0384615	1.9151611137907607
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0384615	1.9151611137907607
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.0384615	1.9151611137907607
KYPHOMELIC DYSPLASIA	0.0384615	1.9151611137907607
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0384615	1.9151611137907607
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0384615	1.9151611137907607
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	1.9151611137907607
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	1.9151611137907607
KYPHOMELIC DYSPLASIA	0.0384615	1.9151611137907607
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0384615	1.9151611137907607
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.0384615	1.9151611137907607
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0384615	1.9151611137907607
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0384615	1.9151611137907607
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0384615	1.9151611137907607
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0384615	1.9151611137907607
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.0384615	1.9151611137907607
22Q11.2 DELETION SYNDROME	0.03815814	1.9000555335227116
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.03807837000000001	1.8960834470974013
SPONDYLO-OCULAR SYNDROME	0.037676259999999996	1.8760606857525126
GALLOWAY-MOWAT SYNDROME	0.037626650000000005	1.873590393567987
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.037142800000000004	1.8494974511474453
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.03709547	1.847140689827275
STARGARDT DISEASE	0.03674451	1.829664903794593
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.829664903794593
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.829664903794593
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.829664903794593
CONE-ROD DYSTROPHY, X-LINKED, 3	0.03674451	1.829664903794593
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.829664903794593
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.829664903794593
ACHROMATOPSIA 7; ACHM7	0.03674451	1.829664903794593
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.03667484	1.8261957391806853
NORRIE DISEASE	0.036556280000000003	1.8202921342341538
SPONDYLOCOSTAL DYSOSTOSIS 5	0.036503999999999995	1.8176888914321572
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.036503999999999995	1.8176888914321572
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.03636619000000001	1.8108267473896347
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.03636619000000001	1.8108267473896347
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.7783663810890724
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7783663810890724
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7783663810890724
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.035714300000000004	1.7783663810890724
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7783663810890724
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	1.7783663810890724
GASTRIC SNEEZING	0.035714300000000004	1.7783663810890724
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7783663810890724
METHANE PRODUCTION	0.035714300000000004	1.7783663810890724
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7783663810890724
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.035714300000000004	1.7783663810890724
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.035714300000000004	1.7783663810890724
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.035714300000000004	1.7783663810890724
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7783663810890724
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.035714300000000004	1.7783663810890724
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7783663810890724
BLUE DIAPER SYNDROME	0.035714300000000004	1.7783663810890724
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7783663810890724
TERATOMA, PINEAL	0.035714300000000004	1.7783663810890724
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.03562709	1.7740238255274408
MUCOPOLYSACCHARIDOSIS TYPE 6	0.034940429999999995	1.739832113545444
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.03471406	1.7285601917189732
ALSTRÖM SYNDROME	0.034643459999999994	1.7250447184630253
COUMARIN RESISTANCE	0.0344828	1.717044776065001
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.717044776065001
MYELOMA, MULTIPLE	0.0344828	1.717044776065001
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.717044776065001
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.717044776065001
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.0344828	1.717044776065001
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.717044776065001
MACROCYTOSIS, FAMILIAL	0.0344828	1.717044776065001
PANNER DISEASE	0.0344828	1.717044776065001
FLOOD FACTOR DEFICIENCY	0.0344828	1.717044776065001
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.717044776065001
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.0344828	1.717044776065001
EOSINOPHILOPENIA	0.0344828	1.717044776065001
CHANARIN-DORFMAN SYNDROME	0.0344828	1.717044776065001
HEMOPOIETIC PROLIFERATION	0.0344828	1.717044776065001
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.717044776065001
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	1.717044776065001
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.717044776065001
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.0344828	1.717044776065001
ACETOPHENETIDIN SENSITIVITY	0.0344828	1.717044776065001
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.717044776065001
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0344828	1.717044776065001
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.03443396	1.7146128254443145
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.7136468172125097
COFS SYNDROME	0.03434863	1.710363883051538
GIANT CELL ARTERITIS	0.03403474	1.6947339694494221
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.033985190000000005	1.6922666649192213
AARSKOG-SCOTT SYNDROME	0.033985190000000005	1.6922666649192213
WIDOW'S PEAK SYNDROME	0.033985190000000005	1.6922666649192213
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.033833289999999995	1.6847029200526706
BRACHYDACTYLY, MONONEN TYPE	0.0333333	1.659806298618659
PELGER-HUET ANOMALY; PHA	0.0333333	1.659806298618659
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0333333	1.659806298618659
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0333333	1.659806298618659
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0333333	1.659806298618659
DIGITOTALAR DYSMORPHISM	0.0333333	1.659806298618659
SPARSE HAIR-SHORT STATURE-SKIN ANOMALIES SYNDROME	0.0333333	1.659806298618659
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0333333	1.659806298618659
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0333333	1.659806298618659
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.0333333	1.659806298618659
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.0333333	1.659806298618659
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0333333	1.659806298618659
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0333333	1.659806298618659
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0333333	1.659806298618659
BRACHYOLMIA	0.0333333	1.659806298618659
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.0333333	1.659806298618659
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.0333333	1.659806298618659
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.0333333	1.659806298618659
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.0333333	1.659806298618659
WEYERS ACROFACIAL DYSOSTOSIS	0.0333333	1.659806298618659
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.03306144	1.6462692368713232
RETINITIS PIGMENTOSA 11	0.032795210000000005	1.633012516688166
SCHWARTZ-JAMPEL SYNDROME	0.03238785	1.6127283355898259
22Q11.2 MICRODUPLICATION SYNDROME	0.03222104	1.6044221586234715
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.03207396	1.5970984219877096
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.5970984219877096
INFANTILE SIALIC ACID STORAGE DISEASE	0.03204403	1.5956080804218387
FATCO SYNDROME	0.03178255	1.5825878828727566
SILVER-RUSSELL SYNDROME	0.03178255	1.5825878828727566
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03177587	1.5822552573578879
SCLEROSTEOSIS 1; SOST1	0.03150184	1.5686101421124587
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.556069961024954
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.556069961024954
ACHROMATOPSIA	0.03125	1.556069961024954
CONE-ROD DYSTROPHY 18	0.03125	1.556069961024954
DISTAL MONOSOMY 7Q36	0.031184069999999998	1.5527870268639818
KAGAMI-OGATA SYNDROME	0.031130659999999998	1.5501275165721948
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.030942360000000002	1.540751261415043
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.030942360000000002	1.540751261415043
EPIDERMAL NEVUS SYNDROME	0.030942360000000002	1.540751261415043
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.03093547	1.5404081791100361
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.03014187	1.5008914712358152
NAVAJO NEUROHEPATOPATHY	0.030063689999999997	1.4969985576501212
SMITH-MAGENIS SYNDROME; SMS	0.030063689999999997	1.4969985576501212
TRICHOHEPATOENTERIC SYNDROME 1	0.030063689999999997	1.4969985576501212
RETINAL CONE DYSTROPHY 4	0.029935669999999998	1.4906238992049883
OMODYSPLASIA 1; OMOD1	0.0298569	1.4867016070184302
OPSISMODYSPLASIA; OPSMD	0.0298569	1.4867016070184302
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.4855414012554902
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.02973858	1.4808099526891991
INTERMEDIATE NEMALINE MYOPATHY	0.02967996	1.47789101441351
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.029644569999999995	1.4761287963040484
BIOTINIDASE DEFICIENCY	0.02941992	1.4649425205682323
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.4645381913495596
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0294118	1.4645381913495596
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.0294118	1.4645381913495596
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0294118	1.4645381913495596
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.4645381913495596
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.4645381913495596
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0294118	1.4645381913495596
RAGWEED SENSITIVITY	0.0294118	1.4645381913495596
MORQUIO SYNDROME A	0.0294118	1.4645381913495596
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0294118	1.4645381913495596
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0294118	1.4645381913495596
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.4645381913495596
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.4645381913495596
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.4645381913495596
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.4645381913495596
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0294118	1.4645381913495596
DIAPHANOSPONDYLODYSOSTOSIS	0.0294118	1.4645381913495596
IMMUNE SUPPRESSION	0.0294118	1.4645381913495596
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.4645381913495596
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.0294118	1.4645381913495596
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.4645381913495596
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.4645381913495596
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	1.4645381913495596
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	1.4645381913495596
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.0294118	1.4645381913495596
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.4645381913495596
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.4645381913495596
MONOMELIC AMYOTROPHY	0.0294118	1.4645381913495596
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0294118	1.4645381913495596
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.4645381913495596
MYASTHENIA GRAVIS; MG	0.0294118	1.4645381913495596
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0294118	1.4645381913495596
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.4645381913495596
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0294118	1.4645381913495596
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.0294118	1.4645381913495596
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.4645381913495596
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0294118	1.4645381913495596
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.0294118	1.4645381913495596
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.4591708703543955
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.4591708703543955
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.4591708703543955
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.4591708703543955
IDIOPATHIC UVEAL EFFUSION SYNDROME	0.029304010000000002	1.4591708703543955
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.02922329	1.4551514794022697
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02922329	1.4551514794022697
C SYNDROME	0.02922329	1.4551514794022697
ACRODYSOSTOSIS	0.02922329	1.4551514794022697
PENTASOMY X	0.02922329	1.4551514794022697
FETAL ALCOHOL SYNDROME	0.02922329	1.4551514794022697
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.02922329	1.4551514794022697
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.02922329	1.4551514794022697
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02922329	1.4551514794022697
STÜVE-WIEDEMANN SYNDROME	0.028685689999999996	1.428382096648765
PROPIONIC ACIDEMIA	0.0285714	1.4226911131017077
CHEILITIS GLANDULARIS	0.0285714	1.4226911131017077
SOTOS SYNDROME	0.0285714	1.4226911131017077
TETRASOMY X	0.0285714	1.4226911131017077
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.4226911131017077
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.4226911131017077
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.4226911131017077
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.4226911131017077
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.4226911131017077
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0285714	1.4226911131017077
ALG12-CDG	0.0285714	1.4226911131017077
ALG1-CDG	0.0285714	1.4226911131017077
COG7-CDG	0.0285714	1.4226911131017077
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.4226911131017077
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.02801596	1.3950334011288534
FIBULAR HEMIMELIA	0.027777800000000002	1.383174405227487
TUFTED ANGIOMA	0.027777800000000002	1.383174405227487
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	1.383174405227487
ACATALASEMIA	0.027777800000000002	1.383174405227487
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	1.383174405227487
CLUSTER HEADACHE, FAMILIAL	0.027777800000000002	1.383174405227487
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.027777800000000002	1.383174405227487
AMYOTROPHIC LATERAL SCLEROSIS	0.027777800000000002	1.383174405227487
EPENDYMOMA	0.027777800000000002	1.383174405227487
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	1.383174405227487
SUBEPENDYMOMA	0.027777800000000002	1.383174405227487
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	1.383174405227487
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	1.383174405227487
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	1.383174405227487
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	1.383174405227487
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.027777800000000002	1.383174405227487
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	1.383174405227487
INTERSTITIAL CYSTITIS	0.027777800000000002	1.383174405227487
BUERGER DISEASE	0.027777800000000002	1.383174405227487
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	1.383174405227487
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.027777800000000002	1.383174405227487
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	1.383174405227487
OSTEOSARCOMA	0.027777800000000002	1.383174405227487
THYROID LYMPHOMA	0.027777800000000002	1.383174405227487
OROMANDIBULAR DYSTONIA	0.027777800000000002	1.383174405227487
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	1.383174405227487
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.027621859999999998	1.3754094916363753
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02736407	1.3625730348282916
ZIMMERMANN-LABAND SYNDROME 1	0.02736407	1.3625730348282916
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	1.3594175739185266
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0273007	1.3594175739185266
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.02727126	1.3579516315296443
CARDIOFACIOCUTANEOUS SYNDROME	0.02714503	1.3516661047718785
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02685278	1.3371137384963732
RETINITIS PIGMENTOSA 10; RP10	0.02677111	1.3330470430174322
RETINITIS PIGMENTOSA 14	0.02677111	1.3330470430174322
RETINITIS PIGMENTOSA 83; RP83	0.02677111	1.3330470430174322
RETINITIS PIGMENTOSA 19	0.02677111	1.3330470430174322
CHERUBISM	0.02677111	1.3330470430174322
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	1.3330470430174322
RETINITIS PIGMENTOSA 72; RP72	0.02677111	1.3330470430174322
RETINITIS PIGMENTOSA 79	0.02677111	1.3330470430174322
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.02642217	1.3156718413470305
MILLER-DIEKER SYNDROME	0.026376939999999998	1.3134196479282414
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.0259601	1.292663417446525
DESBUQUOIS DYSPLASIA 1	0.0259601	1.292663417446525
MEGAEPIPHYSEAL DWARFISM	0.0259601	1.292663417446525
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.0259601	1.292663417446525
DESBUQUOIS SYNDROME	0.0259601	1.292663417446525
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.025889989999999998	1.2891723433675661
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.02577028	1.2832114750464687
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.02577028	1.2832114750464687
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.02577028	1.2832114750464687
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.02565189	1.277316335120525
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.02565189	1.277316335120525
WITTEVEEN-KOLK SYNDROME	0.025578129999999998	1.2736435120701184
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.025379930000000002	1.263774293949314
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02511792	1.2507277054536932
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.02502157	1.245930030549861
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	1.2448559688199632
ANDROGEN INSENSITIVITY SYNDROME	0.025	1.2448559688199632
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	1.2448559688199632
CZECH DYSPLASIA, METATARSAL TYPE	0.025	1.2448559688199632
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	1.2448559688199632
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	1.2448559688199632
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	1.2448559688199632
MAPLE SYRUP URINE DISEASE; MSUD	0.025	1.2448559688199632
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	1.2448559688199632
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	1.2448559688199632
HOOFT DISEASE	0.025	1.2448559688199632
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	1.2448559688199632
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	1.2448559688199632
ZUNICH NEUROECTODERMAL SYNDROME	0.025	1.2448559688199632
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	1.2448559688199632
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	1.2448559688199632
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025	1.2448559688199632
ALKAPTONURIA	0.025	1.2448559688199632
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	1.2448559688199632
MARFANOID HYPERMOBILITY SYNDROME	0.025	1.2448559688199632
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	1.2448559688199632
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02497419	1.2435707795177533
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02492624	1.2411831457695568
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.02472804	1.2313139276487521
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	1.219109359730441
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	1.219109359730441
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.02446139	1.2180362938853182
PSEUDOXANTHOMA ELASTICUM	0.02444116	1.2170289564353491
DERMOCHONDROCORNEAL DYSTROPHY	0.02436241	1.2131076601335662
MUCOLIPIDOSIS TYPE II	0.024292559999999998	1.2096295325566833
INFANTILE REFSUM DISEASE	0.02388927	1.1895480140100672
SNEDDON SYNDROME	0.0238095	1.1855759275847566
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	1.1855759275847566
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	1.1855759275847566
ISOLATED PLAGIOCEPHALY	0.0238095	1.1855759275847566
RETINITIS PIGMENTOSA 62; RP62	0.0238095	1.1855759275847566
LYNCH SYNDROME	0.0238095	1.1855759275847566
CRANIOSYNOSTOSIS 2	0.0238095	1.1855759275847566
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	1.1855759275847566
FAMILIAL COLORECTAL CANCER TYPE X	0.0238095	1.1855759275847566
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.0238095	1.1855759275847566
PITUICYTOMA	0.0238095	1.1855759275847566
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	1.1855759275847566
ADNP SYNDROME	0.02341915	1.1661387464876014
WATSON SYNDROME	0.023379189999999998	1.1641489687070397
FETAL HYDANTOIN SYNDROME	0.023379189999999998	1.1641489687070397
POTOCKI-LUPSKI SYNDROME	0.023379189999999998	1.1641489687070397
LARSEN SYNDROME	0.023379189999999998	1.1641489687070397
MYOTONIA PERMANENS	0.02330939	1.1606733308420945
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.02323738	1.1570876477095053
GERODERMA OSTEODYSPLASTICA	0.023221199999999997	1.156281976926485
SEA-BLUE HISTIOCYTE DISEASE	0.02319737	1.1550953802170059
GAUCHER DISEASE, TYPE I	0.02319737	1.1550953802170059
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0228938	1.139979343158819
COWDEN SYNDROME 6; CWS6	0.0227273	1.1316886024064778
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.1316886024064778
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	1.1316886024064778
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	1.1316886024064778
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.1316886024064778
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.1316886024064778
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0227273	1.1316886024064778
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	1.1316886024064778
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	1.1316886024064778
COCAINE EMBRYOFETOPATHY	0.0227273	1.1316886024064778
THUMB DEFORMITY	0.0227273	1.1316886024064778
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	1.1316886024064778
SIRENOMELIA	0.0227273	1.1316886024064778
ARTERIES, ANOMALIES OF	0.0227273	1.1316886024064778
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.1316886024064778
SILVER-RUSSELL SYNDROME; SRS	0.0227273	1.1316886024064778
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.1316886024064778
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.1316886024064778
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.1316886024064778
COWDEN SYNDROME 5; CWS5	0.0227273	1.1316886024064778
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.1316886024064778
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.1316886024064778
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.1316886024064778
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.1316886024064778
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0227273	1.1316886024064778
BETHLEM MYOPATHY 1	0.0227273	1.1316886024064778
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.1316886024064778
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.1316886024064778
YAO SYNDROME	0.022657499999999997	1.1282129645415324
PERIPARTUM CARDIOMYOPATHY	0.022657499999999997	1.1282129645415324
BRONCHIAL NEUROENDOCRINE TUMOR	0.022657499999999997	1.1282129645415324
POTASSIUM-AGGRAVATED MYOTONIA	0.022657499999999997	1.1282129645415324
OSTEOPETROSIS AND RELATED DISORDERS	0.022142709999999996	1.1025793883739792
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.02192849	1.0919124665483548
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.02192849	1.0919124665483548
PYCNODYSOSTOSIS	0.02192849	1.0919124665483548
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.02192849	1.0919124665483548
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.021683479999999998	1.0797123801115316
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.021683479999999998	1.0797123801115316
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.021683479999999998	1.0797123801115316
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.021673089999999996	1.07919501797089
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.021485189999999998	1.0698386805092392
OSTEOGENESIS IMPERFECTA, TYPE V	0.021485189999999998	1.0698386805092392
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.02133876	1.062547310128667
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.0212766	1.059452100247793
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0212766	1.059452100247793
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0212766	1.059452100247793
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.0212766	1.059452100247793
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.0212766	1.059452100247793
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0212766	1.059452100247793
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.0212766	1.059452100247793
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0212766	1.059452100247793
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 73; RP73	0.0212766	1.059452100247793
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0212766	1.059452100247793
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0212766	1.059452100247793
GALACTORRHEA	0.0212766	1.059452100247793
CRISS-CROSS HEART	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 74; RP74	0.0212766	1.059452100247793
SERTOLI CELL-ONLY SYNDROME	0.0212766	1.059452100247793
FIBROSCLEROSIS, MULTIFOCAL	0.0212766	1.059452100247793
PYLE DISEASE; PYL	0.0212766	1.059452100247793
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0212766	1.059452100247793
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.0212766	1.059452100247793
BREAST, UNILATERAL GIANT	0.0212766	1.059452100247793
OCULOCEREBROCUTANEOUS SYNDROME	0.0212766	1.059452100247793
ACROPECTORAL SYNDROME	0.0212766	1.059452100247793
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 6	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 25; RP25	0.0212766	1.059452100247793
HERNIA, HIATUS	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 1	0.0212766	1.059452100247793
NIPPLES, SUPERNUMERARY	0.0212766	1.059452100247793
CENTRIFUGAL LIPODYSTROPHY	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 13; RP13	0.0212766	1.059452100247793
RETINITIS PIGMENTOSA 69	0.0212766	1.059452100247793
THROMBOCYTHEMIA, ESSENTIAL	0.02123197	1.0572297833722555
CLASSICAL EHLERS-DANLOS SYNDROME	0.02096005	1.0436897339705948
MICROFORM HOLOPROSENCEPHALY	0.02096005	1.0436897339705948
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	1.0373783142086774
STICKLER SYNDROME, TYPE III	0.0208333	1.0373783142086774
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	1.0373783142086774
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	1.0373783142086774
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	1.0373783142086774
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	1.0373783142086774
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	1.0373783142086774
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	1.0373783142086774
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0208333	1.0373783142086774
UNIQUE GREEN PHENOMENON	0.0208333	1.0373783142086774
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	1.0373783142086774
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	1.0373783142086774
HYPERCALCEMIA, INFANTILE, 1	0.0208333	1.0373783142086774
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	1.0373783142086774
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	1.0373783142086774
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	1.0373783142086774
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	1.0373783142086774
611426 TENTED EYEBROWS	0.0208333	1.0373783142086774
PUPIL, EGG-SHAPED	0.0208333	1.0373783142086774
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	1.0373783142086774
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	1.0373783142086774
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	1.0373783142086774
DERMOIDS OF CORNEA	0.0208333	1.0373783142086774
MYELINATED OPTIC NERVE FIBERS	0.0208333	1.0373783142086774
CRANDALL SYNDROME	0.0208333	1.0373783142086774
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	1.0373783142086774
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	1.0373783142086774
POLYARTERITIS NODOSA	0.0208333	1.0373783142086774
IMINOGLYCINURIA	0.0208333	1.0373783142086774
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	1.0373783142086774
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	1.0373783142086774
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	1.0373783142086774
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	1.0373783142086774
CINCA SYNDROME	0.02044117	1.0178524993665428
LINEAR NEVUS SEBACEUS SYNDROME	0.019778639999999997	0.9848623223656509
RETINITIS PIGMENTOSA 80; RP80	0.0197227	0.9820768326498194
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0196592	0.9789148984890169
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.01964807	0.9783606886116982
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01939236	0.9656278038202201
ATELOSTEOGENESIS, TYPE I; AO1	0.01939236	0.9656278038202201
CONE DYSTROPHY 3	0.01919311	0.9557063017487248
CONE-ROD DYSTROPHY 16	0.01919311	0.9557063017487248
EBSTEIN MALFORMATION	0.019156060000000003	0.9538614252029339
FARBER DISEASE	0.019144959999999996	0.9533087091527774
CHOREOACANTHOCYTOSIS	0.019144959999999996	0.9533087091527774
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.9395127173639273
VAN DEN BOSCH SYNDROME	0.0188679	0.9395127173639273
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0188679	0.9395127173639273
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.9395127173639273
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0188679	0.9395127173639273
PSEUDOACHONDROPLASIA	0.0188679	0.9395127173639273
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.9395127173639273
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.9395127173639273
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0188679	0.9395127173639273
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.9395127173639273
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.9395127173639273
BAND HETEROTOPIA; BH	0.0188679	0.9395127173639273
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.9395127173639273
SCHNECKENBECKEN DYSPLASIA	0.0188679	0.9395127173639273
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.9395127173639273
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.9395127173639273
THUMBS, CONGENITAL CLASPED	0.0188679	0.9395127173639273
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0188679	0.9395127173639273
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.0188679	0.9395127173639273
LERI-WEILL DYSCHONDROSTOSIS (LWD) - SHOX DELETION	0.0188679	0.9395127173639273
PUBIC BONE DYSPLASIA	0.0188679	0.9395127173639273
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.9395127173639273
THORACOMELIC DYSPLASIA	0.0188679	0.9395127173639273
RAYNAUD DISEASE	0.0188679	0.9395127173639273
THORACOMELIC DYSPLASIA	0.0188679	0.9395127173639273
THROMBOCYTOPENIA 3	0.0188679	0.9395127173639273
LETTERER-SIWE DISEASE	0.0188679	0.9395127173639273
THANATOPHORIC DYSPLASIA	0.0188679	0.9395127173639273
ASTLEY-KENDALL DYSPLASIA	0.0188679	0.9395127173639273
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0188679	0.9395127173639273
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.0188679	0.9395127173639273
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.0188679	0.9395127173639273
MADELUNG DEFORMITY	0.0188679	0.9395127173639273
MONOPHALANGY OF GREAT TOE	0.0188679	0.9395127173639273
CARPAL DISPLACEMENT	0.0188679	0.9395127173639273
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.0188679	0.9395127173639273
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.9395127173639273
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.9395127173639273
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.9395127173639273
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.9395127173639273
LERI-WEILL DYSCHONDROSTEOSIS	0.0188679	0.9395127173639273
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.9395127173639273
NEPHROSIALIDOSIS	0.0188679	0.9395127173639273
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.9395127173639273
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.9395127173639273
SLC39A8-CDG	0.0188679	0.9395127173639273
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.9395127173639273
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.0188679	0.9395127173639273
OSTEOGENESIS IMPERFECTA, TYPE IX	0.0188679	0.9395127173639273
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0188679	0.9395127173639273
SCHNECKENBECKEN DYSPLASIA	0.0188679	0.9395127173639273
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.9395127173639273
ACHONDROGENESIS TYPE 2	0.0188679	0.9395127173639273
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.0188679	0.9395127173639273
HHHH SYNDROME	0.0188679	0.9395127173639273
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.0188679	0.9395127173639273
KNUCKLE PADS	0.0188679	0.9395127173639273
CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	0.0188679	0.9395127173639273
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.9395127173639273
HYPOPHOSPHATASIA, INFANTILE	0.0188679	0.9395127173639273
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.9395127173639273
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0188679	0.9395127173639273
VESICOURETERAL REFLUX 1	0.0188679	0.9395127173639273
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.9395127173639273
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0188679	0.9395127173639273
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.9395127173639273
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.9395127173639273
TOE, MISSHAPEN	0.0188679	0.9395127173639273
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0188679	0.9395127173639273
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.9395127173639273
HEMIMELIA	0.0188679	0.9395127173639273
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0188679	0.9395127173639273
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.0188679	0.9395127173639273
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.9395127173639273
SPINAL ARACHNOIDITIS	0.0188679	0.9395127173639273
TRACHEOBRONCHOMEGALY	0.0188679	0.9395127173639273
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.9395127173639273
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.9395127173639273
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.01874167	0.9332271906061614
CEDNIK SYNDROME	0.01874167	0.9332271906061614
CONGENITAL HYPOTHYROIDISM	0.01874167	0.9332271906061614
FETAL CYTOMEGALOVIRUS SYNDROME	0.018493069999999997	0.9208483428522157
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.018089779999999996	0.9007668243055995
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.018089779999999996	0.9007668243055995
MCCUNE-ALBRIGHT SYNDROME	0.018089779999999996	0.9007668243055995
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.018089779999999996	0.9007668243055995
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.018089779999999996	0.9007668243055995
TRISOMY 13	0.018089779999999996	0.9007668243055995
OSTEOGLOSPHONIC DYSPLASIA	0.0180812	0.9003395897371006
PSEUDODIASTROPHIC DYSPLASIA	0.0180812	0.9003395897371006
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.0180812	0.9003395897371006
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0180812	0.9003395897371006
DISTAL TRISOMY 17Q	0.0180812	0.9003395897371006
HYPERTRICHOSIS CUBITI	0.0180812	0.9003395897371006
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.01769842	0.8812793510273045
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.01698294	0.8456525690844522
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01691383	0.8422112892442463
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01688925	0.8409873468557026
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.01686316	0.8396882151666418
GORLIN-CHAUDHRY-MOSS SYNDROME	0.016780889999999996	0.8355916431444491
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016780889999999996	0.8355916431444491
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016780889999999996	0.8355916431444491
DYSEQUILIBRIUM SYNDROME	0.016780889999999996	0.8355916431444491
TOWNES-BROCKS SYNDROME	0.016780889999999996	0.8355916431444491
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016780889999999996	0.8355916431444491
6Q25 MICRODELETION SYNDROME	0.016780889999999996	0.8355916431444491
SARCOIDOSIS	0.0167768	0.8353879847079504
SIALIDOSIS TYPE 1	0.016714559999999996	0.832288791287976
NEURAMINIDASE DEFICIENCY	0.016714559999999996	0.832288791287976
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.01649786	0.8214983797502446
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.016311269999999996	0.8122072727413597
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.01624934	0.8091235155353992
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.8031312768438872
MULTIPLE CARBOXYLASE DEFICIENCY	0.016128999999999998	0.8031312768438872
ALKAPTONURIA	0.016128999999999998	0.8031312768438872
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.8031312768438872
CENTRAL NEUROCYTOMA	0.016128999999999998	0.8031312768438872
FETAL PARVOVIRUS SYNDROME	0.016128999999999998	0.8031312768438872
X-LINKED RETINOSCHISIS	0.016128999999999998	0.8031312768438872
ACRORENAL SYNDROME	0.016128999999999998	0.8031312768438872
CEREBROTENDINOUS XANTHOMATOSIS	0.016128999999999998	0.8031312768438872
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016128999999999998	0.8031312768438872
SILENT SINUS SYNDROME	0.016128999999999998	0.8031312768438872
ALG3-CDG	0.016128999999999998	0.8031312768438872
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.8031312768438872
WAARDENBURG SYNDROME	0.016128999999999998	0.8031312768438872
PREECLAMPSIA	0.016128999999999998	0.8031312768438872
STERNAL CLEFT	0.016128999999999998	0.8031312768438872
INSULINOMA	0.016128999999999998	0.8031312768438872
1P21.3 MICRODELETION SYNDROME	0.016128999999999998	0.8031312768438872
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.8031312768438872
DPM1-CDG	0.016128999999999998	0.8031312768438872
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.016128999999999998	0.8031312768438872
ALG11-CDG	0.016128999999999998	0.8031312768438872
ARACHNOIDITIS	0.016128999999999998	0.8031312768438872
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016128999999999998	0.8031312768438872
RECOMBINANT 8 SYNDROME	0.016128999999999998	0.8031312768438872
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.8031312768438872
BENIGN FAMILIAL INFANTILE EPILEPSY	0.016128999999999998	0.8031312768438872
NARCOLEPSY TYPE 1	0.016128999999999998	0.8031312768438872
WAARDENBURG SYNDROME TYPE 1	0.016128999999999998	0.8031312768438872
EEM SYNDROME	0.016128999999999998	0.8031312768438872
MPDU1-CDG	0.016128999999999998	0.8031312768438872
DIPROSOPUS	0.016128999999999998	0.8031312768438872
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01611434	0.8024012933037715
PETERS PLUS SYNDROME	0.01611434	0.8024012933037715
REFSUM DISEASE	0.016062669999999998	0.7998284249874141
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.01596574	0.7950018694251055
OPTIC ATROPHY 11; OPA11	0.01594597	0.7940174373249627
SAETHRE-CHOTZEN SYNDROME	0.01594597	0.7940174373249627
CHÉDIAK-HIGASHI SYNDROME	0.01569737	0.781638589571017
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.015659379999999997	0.779746906440798
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.015659379999999997	0.779746906440798
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.015659379999999997	0.779746906440798
CHERUBISM	0.015659379999999997	0.779746906440798
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.015659379999999997	0.779746906440798
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.015659379999999997	0.779746906440798
BEHR SYNDROME	0.015659379999999997	0.779746906440798
HSD10 DISEASE	0.015659379999999997	0.779746906440798
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.015659379999999997	0.779746906440798
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.01549556	0.7715896142483147
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.01549556	0.7715896142483147
CORNEODERMATOOSSEOUS SYNDROME	0.01549556	0.7715896142483147
JACOBSEN SYNDROME	0.01529408	0.7615570710244008
CROUZON DISEASE	0.01529408	0.7615570710244008
CLASSIC HOMOCYSTINURIA	0.01529408	0.7615570710244008
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.01529408	0.7615570710244008
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.01504438	0.7491234496078271
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.01504438	0.7491234496078271
CASPASE 8 DEFICIENCY	0.014920759999999998	0.742967885813206
CHROMOSOME 18Q DELETION SYNDROME	0.014517469999999998	0.72288636726659
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.7184043878364508
KID SYNDROME	0.014350489999999999	0.7145717252796476
SENIOR-LOKEN SYNDROME	0.014350489999999999	0.7145717252796476
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.014350489999999999	0.7145717252796476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.014350489999999999	0.7145717252796476
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.01428856	0.7114879680736869
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01428856	0.7114879680736869
ADRENOLEUKODYSTROPHY	0.01428856	0.7114879680736869
SPINOCEREBELLAR ATAXIA TYPE 7	0.01428856	0.7114879680736869
SYSTEMIC MASTOCYTOSIS	0.014268869999999998	0.7105075195126441
TRANSALDOLASE DEFICIENCY	0.014268869999999998	0.7105075195126441
CUTANEOUS MASTOCYTOSIS	0.014268869999999998	0.7105075195126441
MASTOCYTOSIS	0.014268869999999998	0.7105075195126441
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.014268869999999998	0.7105075195126441
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.014268869999999998	0.7105075195126441
ZELLWEGER SYNDROME	0.014180590000000002	0.7061116841155474
PELIZAEUS-MERZBACHER DISEASE	0.014180590000000002	0.7061116841155474
CARTILAGE-HAIR HYPOPLASIA	0.01415356	0.7047657458420591
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01398519	0.6963818898632503
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.01398519	0.6963818898632503
DIGEORGE SYNDROME; DGS	0.01398519	0.6963818898632503
SPONDYLOOCULAR SYNDROME; SOS	0.01398519	0.6963818898632503
MARSHALL SYNDROME	0.01398519	0.6963818898632503
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.01398519	0.6963818898632503
WILLIAMS-BEUREN SYNDROME; WBS	0.01398519	0.6963818898632503
OCULOCEREBRORENAL SYNDROME OF LOWE	0.01398519	0.6963818898632503
GRANULOMATOSIS WITH POLYANGIITIS	0.01391726	0.6929993672247728
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.01375881	0.6851094700943918
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.013698599999999998	0.6821113589790858
MEDULLOBLASTOMA	0.013698599999999998	0.6821113589790858
JOUBERT SYNDROME 35; JBTS35	0.013698599999999998	0.6821113589790858
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.6821113589790858
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.6821113589790858
ANIRIDIA 3	0.013698599999999998	0.6821113589790858
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.6821113589790858
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.6821113589790858
BASAL LAMINAR DRUSEN	0.013698599999999998	0.6821113589790858
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.6821113589790858
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.013698599999999998	0.6821113589790858
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.6821113589790858
DONNAI-BARROW SYNDROME	0.013698599999999998	0.6821113589790858
CHOROIDEREMIA	0.013698599999999998	0.6821113589790858
KNOBLOCH SYNDROME	0.013698599999999998	0.6821113589790858
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.013698599999999998	0.6821113589790858
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013698599999999998	0.6821113589790858
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.6821113589790858
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.6821113589790858
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.013698599999999998	0.6821113589790858
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.6821113589790858
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.6821113589790858
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.6821113589790858
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0133801	0.6662518939363196
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.01335307	0.6649059556628314
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.6639215235626885
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.0133333	0.6639215235626885
CATARACT 17, MULTIPLE TYPES	0.0133333	0.6639215235626885
19P13.3 MICRODUPLICATION SYNDROME	0.0133333	0.6639215235626885
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.6639215235626885
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0133333	0.6639215235626885
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0133333	0.6639215235626885
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.6639215235626885
PHACE SYNDROME	0.0133333	0.6639215235626885
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0133333	0.6639215235626885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0133333	0.6639215235626885
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0133333	0.6639215235626885
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.6639215235626885
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0133333	0.6639215235626885
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0133333	0.6639215235626885
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.0133333	0.6639215235626885
MORNING GLORY DISC ANOMALY	0.0133333	0.6639215235626885
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0133333	0.6639215235626885
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0133333	0.6639215235626885
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.0133333	0.6639215235626885
RAHMAN SYNDROME	0.0133333	0.6639215235626885
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0133333	0.6639215235626885
TETRASOMY 9P	0.0133333	0.6639215235626885
DUANE RETRACTION SYNDROME	0.0133333	0.6639215235626885
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.0133333	0.6639215235626885
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.0133333	0.6639215235626885
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.0133333	0.6639215235626885
BENCZE SYNDROME	0.0133333	0.6639215235626885
PFEIFFER SYNDROME TYPE 3	0.0133333	0.6639215235626885
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.0133333	0.6639215235626885
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0133333	0.6639215235626885
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.6639215235626885
ISOLATED ECTOPIA LENTIS	0.0133333	0.6639215235626885
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0133333	0.6639215235626885
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0133333	0.6639215235626885
MUENKE SYNDROME	0.0133333	0.6639215235626885
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0133333	0.6639215235626885
MIXED CONNECTIVE TISSUE DISEASE	0.01311677	0.653139577045545
WHIPPLE DISEASE	0.01311677	0.653139577045545
HODGKIN LYMPHOMA	0.01311677	0.653139577045545
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.01311677	0.653139577045545
ESSENTIAL THROMBOCYTHEMIA	0.01311677	0.653139577045545
CLASSIC HODGKIN LYMPHOMA	0.01311677	0.653139577045545
PLAGUE	0.01311677	0.653139577045545
KAPOSIFORM LYMPHANGIOMATOSIS	0.01311677	0.653139577045545
LEGIONELLOSIS	0.01311677	0.653139577045545
FAMILIAL MEDITERRANEAN FEVER	0.01311677	0.653139577045545
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.013116300000000001	0.6531161737533314
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0130836	0.6514879021461149
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0130836	0.6514879021461149
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0130836	0.6514879021461149
SMITH-LEMLI-OPITZ SYNDROME	0.012949780000000001	0.6448244371162154
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.012949780000000001	0.6448244371162154
LYMPHANGIOLEIOMYOMATOSIS	0.012713480000000001	0.633058058498929
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.01258931	0.6268751078729939
RAMOS-ARROYO SYNDROME	0.012586710000000001	0.6267456428522368
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012556689999999999	0.6252508198048776
SECKEL SYNDROME 9; SCKL9	0.012556689999999999	0.6252508198048776
NETHERTON SYNDROME	0.012556689999999999	0.6252508198048776
OCULO-PALATO-CEREBRAL SYNDROME	0.012556689999999999	0.6252508198048776
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.012556689999999999	0.6252508198048776
49,XXXXY SYNDROME	0.012556689999999999	0.6252508198048776
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.012556689999999999	0.6252508198048776
PGM3-CDG	0.012556689999999999	0.6252508198048776
DUBOWITZ SYNDROME	0.012556689999999999	0.6252508198048776
16P13.2 MICRODELETION SYNDROME	0.012556689999999999	0.6252508198048776
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012556689999999999	0.6252508198048776
IMMUNODEFICIENCY 58; IMD58	0.012556689999999999	0.6252508198048776
BRAIN-LUNG-THYROID SYNDROME	0.012556689999999999	0.6252508198048776
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.012556689999999999	0.6252508198048776
XFE PROGEROID SYNDROME; XFEPS	0.01221754	0.6083631037318661
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01208091	0.6015597168910712
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.012046630000000001	0.5998527703866253
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.01204663	0.5998527703866252
ZTTK SYNDROME; ZTTKS	0.01204663	0.5998527703866252
WHITE-SUTTON SYNDROME; WHSUS	0.01204663	0.5998527703866252
MICRO SYNDROME	0.01204663	0.5998527703866252
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0119141	0.593253539924717
48,XXYY SYNDROME	0.011904799999999998	0.5927904535043158
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011904799999999998	0.5927904535043158
DERMATITIS, ATOPIC	0.011904799999999998	0.5927904535043158
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.5927904535043158
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	0.5927904535043158
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011904799999999998	0.5927904535043158
CYSTIC FIBROSIS	0.011904799999999998	0.5927904535043158
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.5927904535043158
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.5927904535043158
ICHTHYOSIS VULGARIS	0.011904799999999998	0.5927904535043158
CARCINOID SYNDROME	0.011904799999999998	0.5927904535043158
AORTIC ARCH DEFECTS	0.011904799999999998	0.5927904535043158
47,XYY SYNDROME	0.011904799999999998	0.5927904535043158
BARDET-BIEDL SYNDROME 1; BBS1	0.011904799999999998	0.5927904535043158
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	0.5927904535043158
48,XYYY SYNDROME	0.011904799999999998	0.5927904535043158
BERNARD-SOULIER SYNDROME	0.011904799999999998	0.5927904535043158
NETHERTON SYNDROME; NETH	0.011904799999999998	0.5927904535043158
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.5927904535043158
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.5927904535043158
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011904799999999998	0.5927904535043158
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011904799999999998	0.5927904535043158
IMMUNODEFICIENCY 23; IMD23	0.011904799999999998	0.5927904535043158
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.5927904535043158
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.5927904535043158
CHILBLAIN LUPUS	0.011904799999999998	0.5927904535043158
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.011904799999999998	0.5927904535043158
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.011904799999999998	0.5927904535043158
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.5927904535043158
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	0.5927904535043158
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	0.5927904535043158
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.5927904535043158
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.5927904535043158
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	0.5927904535043158
48,XXXY SYNDROME	0.011904799999999998	0.5927904535043158
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	0.5927904535043158
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01179803	0.5874739226326795
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.01156792	0.5760157703532731
CONGENITAL TOXOPLASMOSIS	0.01156792	0.5760157703532731
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.5735604164403728
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.5735604164403728
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.01142902	0.5690993505905094
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.01142902	0.5690993505905094
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01142902	0.5690993505905094
ROIFMAN SYNDROME; RFMN	0.01141932	0.5686163464746072
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.011404590000000001	0.5678828773377785
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.011404590000000001	0.5678828773377785
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.011404590000000001	0.5678828773377785
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.01139474	0.5673924040860635
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01139474	0.5673924040860635
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.01139474	0.5673924040860635
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.01139474	0.5673924040860635
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.01139474	0.5673924040860635
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.01139474	0.5673924040860635
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01139474	0.5673924040860635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.01139474	0.5673924040860635
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.01139474	0.5673924040860635
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.01139474	0.5673924040860635
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01139474	0.5673924040860635
SCHINDLER DISEASE, TYPE I	0.01139474	0.5673924040860635
AMISH INFANTILE EPILEPSY SYNDROME	0.01139474	0.5673924040860635
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.01139474	0.5673924040860635
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.01139474	0.5673924040860635
COHEN SYNDROME	0.011271739999999999	0.5612677127194692
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.011139050000000001	0.5546605151793605
DISTAL MONOSOMY 17Q	0.011016030000000001	0.5485348279279911
GM1 GANGLIOSIDOSIS	0.011000840000000001	0.5477784534413362
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.010989	0.5471888896545031
COG1-CDG	0.010989	0.5471888896545031
CRANIOECTODERMAL DYSPLASIA 1	0.010989	0.5471888896545031
PSEUDODIASTROPHIC DYSPLASIA	0.010989	0.5471888896545031
SPONDYLOENCHONDRODYSPLASIA	0.010989	0.5471888896545031
AUTOSOMAL DOMINANT OMODYSPLASIA	0.010989	0.5471888896545031
CRANIOECTODERMAL DYSPLASIA	0.010989	0.5471888896545031
FIBROCHONDROGENESIS 1; FBCG1	0.010989	0.5471888896545031
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.010989	0.5471888896545031
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.010989	0.5471888896545031
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	0.010989	0.5471888896545031
SPONASTRIME DYSPLASIA	0.010989	0.5471888896545031
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.010989	0.5471888896545031
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.010989	0.5471888896545031
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.010989	0.5471888896545031
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.010989	0.5471888896545031
SPONDYLOMETAPHYSEAL DYSPLASIA	0.010989	0.5471888896545031
WIEDEMANN-STEINER SYNDROME	0.010989	0.5471888896545031
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.010989	0.5471888896545031
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.010989	0.5471888896545031
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010989	0.5471888896545031
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.010989	0.5471888896545031
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.010989	0.5471888896545031
CLEIDORHIZOMELIC SYNDROME	0.010989	0.5471888896545031
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.010989	0.5471888896545031
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.010989	0.5471888896545031
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.010989	0.5471888896545031
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.010989	0.5471888896545031
CLEIDORHIZOMELIC SYNDROME	0.010989	0.5471888896545031
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.010989	0.5471888896545031
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.010989	0.5471888896545031
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.010989	0.5471888896545031
INIENCEPHALY	0.010989	0.5471888896545031
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.010989	0.5471888896545031
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.010989	0.5471888896545031
RHIZOMELIC SYNDROME	0.010989	0.5471888896545031
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.010989	0.5471888896545031
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.010989	0.5471888896545031
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.010989	0.5471888896545031
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010989	0.5471888896545031
SMITH-KINGSMORE SYNDROME; SKS	0.010989	0.5471888896545031
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.010989	0.5471888896545031
RHIZOMELIC SYNDROME, URBACH TYPE	0.010989	0.5471888896545031
SHORT RIB-POLYDACTYLY SYNDROME	0.010989	0.5471888896545031
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.010989	0.5471888896545031
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.010877129999999999	0.5416184081652273
BECKWITH-WIEDEMANN SYNDROME	0.01076743	0.5361559801740454
PEDIATRIC-ONSET GRAVES DISEASE	0.01076743	0.5361559801740454
GAUCHER DISEASE, PERINATAL LETHAL	0.01076743	0.5361559801740454
KAGAMI-OGATA SYNDROME	0.01076743	0.5361559801740454
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.0107527	0.5354225110372167
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0107527	0.5354225110372167
DPM3-CDG	0.0107527	0.5354225110372167
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	0.0107527	0.5354225110372167
CHRONIC GRAFT VERSUS HOST DISEASE	0.0107527	0.5354225110372167
THYMIC CARCINOMA	0.0107527	0.5354225110372167
ADENOCARCINOMA OF THE ESOPHAGUS	0.0107527	0.5354225110372167
THYMOMA	0.0107527	0.5354225110372167
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0107527	0.5354225110372167
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5354225110372167
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5354225110372167
DESMOID TUMOR	0.0107527	0.5354225110372167
ANEURYSM OF SINUS OF VALSALVA	0.0107527	0.5354225110372167
MARBURG HEMORRHAGIC FEVER	0.0107527	0.5354225110372167
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.0107527	0.5354225110372167
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0107527	0.5354225110372167
SCLERODERMA	0.0107527	0.5354225110372167
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0107527	0.5354225110372167
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.0107527	0.5354225110372167
ANTISYNTHETASE SYNDROME	0.0107527	0.5354225110372167
FAMILIAL ATRIAL MYXOMA	0.0107527	0.5354225110372167
IDIOPATHIC BRONCHIECTASIS	0.0107527	0.5354225110372167
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0107527	0.5354225110372167
TAKAYASU ARTERITIS	0.0107527	0.5354225110372167
RHEUMATIC FEVER	0.0107527	0.5354225110372167
HUGHES-STOVIN SYNDROME	0.0107527	0.5354225110372167
NON-FUNCTIONING PARAGANGLIOMA	0.0107527	0.5354225110372167
FAMILIAL AORTIC DISSECTION	0.0107527	0.5354225110372167
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0107527	0.5354225110372167
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.0107527	0.5354225110372167
THYMIC TUMOR	0.0107527	0.5354225110372167
MALAKOPLAKIA	0.0107527	0.5354225110372167
THYMIC EPITHELIAL NEOPLASM	0.0107527	0.5354225110372167
PLEURAL MESOTHELIOMA	0.0107527	0.5354225110372167
PULMONARY BLASTOMA	0.0107527	0.5354225110372167
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.0107527	0.5354225110372167
MYOTONIA FLUCTUANS	0.0107527	0.5354225110372167
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0107527	0.5354225110372167
SAPHO SYNDROME	0.0107527	0.5354225110372167
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.0107527	0.5354225110372167
PORPHYRIA	0.0107527	0.5354225110372167
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0107527	0.5354225110372167
EOSINOPHILIC ESOPHAGITIS	0.0107527	0.5354225110372167
AUTOIMMUNE HYPOPARATHYROIDISM	0.0107527	0.5354225110372167
WISKOTT-ALDRICH SYNDROME	0.0107527	0.5354225110372167
CARCINOMA OF ESOPHAGUS	0.0107527	0.5354225110372167
SYSTEMIC SCLEROSIS	0.0107527	0.5354225110372167
THYMIC NEUROENDOCRINE TUMOR	0.0107527	0.5354225110372167
HYPERKALEMIC PERIODIC PARALYSIS	0.0107527	0.5354225110372167
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0107527	0.5354225110372167
EISENMENGER SYNDROME	0.0107527	0.5354225110372167
EBOLA HEMORRHAGIC FEVER	0.0107527	0.5354225110372167
PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5354225110372167
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.0107527	0.5354225110372167
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.0107527	0.5354225110372167
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0107527	0.5354225110372167
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0107527	0.5354225110372167
GLUTAMATE MONOSODIUM SENSITIVITY	0.0107527	0.5354225110372167
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.0107527	0.5354225110372167
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0107527	0.5354225110372167
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.0107527	0.5354225110372167
BLAU SYNDROME	0.010628529999999999	0.5292395604112816
LCAT DEFICIENCY	0.010628529999999999	0.5292395604112816
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.010628529999999999	0.5292395604112816
TAY-SACHS DISEASE	0.01034895	0.5153180871407743
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.01034895	0.5153180871407743
PEHO SYNDROME	0.01022524	0.5091580418646655
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.01022524	0.5091580418646655
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01022524	0.5091580418646655
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.01022524	0.5091580418646655
OPTICOCOCHLEODENTATE DEGENERATION	0.01022524	0.5091580418646655
NEURONAL CEROID LIPOFUSCINOSIS	0.01022524	0.5091580418646655
LEBER OPTIC ATROPHY AND DYSTONIA	0.01022524	0.5091580418646655
SRD5A3-CDG	0.01022524	0.5091580418646655
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01022524	0.5091580418646655
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.01022524	0.5091580418646655
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.01022524	0.5091580418646655
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.01022524	0.5091580418646655
SEVERE CANAVAN DISEASE	0.01022524	0.5091580418646655
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.01008585	0.502217222924913
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.01008585	0.502217222924913
COG5-CDG	0.01008585	0.502217222924913
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.01008585	0.502217222924913
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.01008585	0.502217222924913
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.01008585	0.502217222924913
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.01008585	0.502217222924913
CHROMOSOME XP11.3 DELETION SYNDROME	0.009840550000000002	0.4900026961588516
MICROPHTHALMIA, SYNDROMIC 1	0.00967374	0.4816965191924972
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00967374	0.4816965191924972
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00967374	0.4816965191924972
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00967374	0.4816965191924972
DESMOSTEROLOSIS	0.00945627	0.4708677660909261
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00945627	0.4708677660909261
OPSISMODYSPLASIA	0.00945627	0.4708677660909261
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00945627	0.4708677660909261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00943396	0.4697568566243511
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00943396	0.4697568566243511
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00943396	0.4697568566243511
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00943396	0.4697568566243511
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00943396	0.4697568566243511
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00943396	0.4697568566243511
POSTERIOR CORTICAL ATROPHY	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.00943396	0.4697568566243511
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00943396	0.4697568566243511
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00943396	0.4697568566243511
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00943396	0.4697568566243511
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00943396	0.4697568566243511
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00943396	0.4697568566243511
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00943396	0.4697568566243511
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.00943396	0.4697568566243511
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00943396	0.4697568566243511
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00943396	0.4697568566243511
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.00943396	0.4697568566243511
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00943396	0.4697568566243511
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00943396	0.4697568566243511
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00943396	0.4697568566243511
YOU-HOOVER-FONG SYNDROME; YHFS	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00943396	0.4697568566243511
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.00943396	0.4697568566243511
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00943396	0.4697568566243511
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.4697568566243511
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.4697568566243511
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.00943396	0.4697568566243511
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00943396	0.4697568566243511
PHELAN-MCDERMID SYNDROME	0.00943396	0.4697568566243511
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00943396	0.4697568566243511
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00943396	0.4697568566243511
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00943396	0.4697568566243511
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.00943396	0.4697568566243511
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.00943396	0.4697568566243511
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00943396	0.4697568566243511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.4697568566243511
RAYNAUD-CLAES SYNDROME; MRXSRC	0.00943396	0.4697568566243511
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00943396	0.4697568566243511
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.00943396	0.4697568566243511
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00943396	0.4697568566243511
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00943396	0.4697568566243511
LOWE OCULOCEREBRORENAL SYNDROME	0.00931096	0.46363216525775697
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00931096	0.46363216525775697
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.45754232985828974
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00917827	0.45702496771764817
COLOBOMA, OCULAR	0.00914415	0.45532598829140264
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00914415	0.45532598829140264
JACOBSEN SYNDROME	0.00905525	0.45089928046627886
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00905525	0.45089928046627886
CORNEODERMATOOSSEOUS SYNDROME	0.00905525	0.45089928046627886
TYSHCHENKO SYNDROME	0.00905525	0.45089928046627886
TEMPLE SYNDROME	0.00905525	0.45089928046627886
CORNELIA DE LANGE SYNDROME	0.00905525	0.45089928046627886
VELO-FACIAL-SKELETAL SYNDROME	0.00905525	0.45089928046627886
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00905525	0.45089928046627886
COSTELLO SYNDROME; CSTLO	0.00905525	0.45089928046627886
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00905525	0.45089928046627886
TEMPLE SYNDROME	0.00905525	0.45089928046627886
DISTAL MONOSOMY 10Q	0.00905525	0.45089928046627886
FG SYNDROME TYPE 1	0.00905525	0.45089928046627886
VASCULAR EHLERS-DANLOS SYNDROME	0.00905525	0.45089928046627886
DIAMOND-BLACKFAN ANEMIA 1	0.00905525	0.45089928046627886
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00905525	0.45089928046627886
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00905525	0.45089928046627886
GMS SYNDROME	0.00905525	0.45089928046627886
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00905525	0.45089928046627886
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00905525	0.45089928046627886
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00905525	0.45089928046627886
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00905298	0.45078624754431
MARINESCO-SJÖGREN SYNDROME	0.00905298	0.45078624754431
FILIPPI SYNDROME	0.00905298	0.45078624754431
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00904006	0.45014290597962386
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00891635	0.4439828607035151
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00891635	0.4439828607035151
WEILL-MARCHESANI SYNDROME	0.00891635	0.4439828607035151
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00891635	0.4439828607035151
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00891635	0.4439828607035151
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00877498	0.436943449171032
CHROMOSOME 1P36 DELETION SYNDROME	0.00877498	0.436943449171032
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.4311717989571951
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.4311717989571951
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.4311717989571951
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.4311717989571951
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00865907	0.4311717989571951
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00865907	0.4311717989571951
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00865907	0.4311717989571951
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.4311717989571951
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00865907	0.4311717989571951
CONE DYSTROPHY 4	0.00865907	0.4311717989571951
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.4311717989571951
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00865907	0.4311717989571951
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.008636770000000002	0.4300613874330078
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.008636770000000002	0.4300613874330078
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.41843891416571705
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.41843891416571705
VACTERL/VATER ASSOCIATION	0.00840336	0.41843891416571705
RENAL TUBULAR DYSGENESIS	0.00840336	0.41843891416571705
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.41843891416571705
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.41843891416571705
HEC SYNDROME	0.00840336	0.41843891416571705
HYDROLETHALUS	0.00840336	0.41843891416571705
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.41843891416571705
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.41843891416571705
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.41843891416571705
NEMALINE MYOPATHY 10	0.00840336	0.41843891416571705
SCHISIS ASSOCIATION	0.00840336	0.41843891416571705
ROBERTS SYNDROME	0.00840336	0.41843891416571705
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.41843891416571705
PEMPHIGOID GESTATIONIS	0.00840336	0.41843891416571705
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.41843891416571705
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.41843891416571705
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.41843891416571705
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	0.41843891416571705
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.41843891416571705
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.41843891416571705
OMPHALOCELE	0.00840336	0.41843891416571705
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.41843891416571705
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.41843891416571705
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.41843891416571705
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.41843891416571705
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00840336	0.41843891416571705
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.41843891416571705
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.41843891416571705
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.41843891416571705
ADAMS-OLIVER SYNDROME	0.00840336	0.41843891416571705
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.41843891416571705
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.41843891416571705
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.41843891416571705
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.41843891416571705
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00840336	0.41843891416571705
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.41843891416571705
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.41843891416571705
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.41843891416571705
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.41843891416571705
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.41843891416571705
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.41843891416571705
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.41843891416571705
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.41843891416571705
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.41843891416571705
SANDHOFF DISEASE	0.00838817	0.41768253967906205
WYBURN-MASON SYNDROME	0.00826446	0.4115224944029533
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.4115224944029533
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.00826446	0.4115224944029533
ECTODERMAL DYSPLASIA SYNDROME	0.00826446	0.4115224944029533
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00826446	0.4115224944029533
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.4115224944029533
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00826446	0.4115224944029533
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.00826446	0.4115224944029533
TOXIC EPIDERMAL NECROLYSIS	0.00826446	0.4115224944029533
STICKLER SYNDROME TYPE 1	0.00826446	0.4115224944029533
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.4115224944029533
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.4115224944029533
UVEAL MELANOMA	0.00826446	0.4115224944029533
GLIOBLASTOMA	0.00826446	0.4115224944029533
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.4115224944029533
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.4115224944029533
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.4115224944029533
CONGENITAL GLAUCOMA	0.00826446	0.4115224944029533
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00826446	0.4115224944029533
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.4115224944029533
MYOCLONIC EPILEPSY OF LAFORA	0.00826446	0.4115224944029533
NEUROMYELITIS OPTICA	0.00826446	0.4115224944029533
PFEIFFER SYNDROME TYPE 2	0.00826446	0.4115224944029533
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.4115224944029533
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00826446	0.4115224944029533
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.4115224944029533
TYROSINEMIA TYPE 2	0.00826446	0.4115224944029533
ISOLATED ANIRIDIA	0.00826446	0.4115224944029533
NANCE-HORAN SYNDROME	0.00826446	0.4115224944029533
KNOBLOCH SYNDROME 1; KNO1	0.00826446	0.4115224944029533
SUSAC SYNDROME	0.00826446	0.4115224944029533
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.4115224944029533
CUSHING DISEASE	0.00826446	0.4115224944029533
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00826446	0.4115224944029533
NANCE-HORAN SYNDROME	0.00826446	0.4115224944029533
BRITTLE CORNEA SYNDROME	0.00826446	0.4115224944029533
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00826446	0.4115224944029533
CATARACT 44; CTRCT44	0.00826446	0.4115224944029533
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.4115224944029533
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.4115224944029533
BRITTLE CORNEA SYNDROME	0.00826446	0.4115224944029533
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00826446	0.4115224944029533
X-LINKED CORNEAL DERMOID	0.00826446	0.4115224944029533
MUCOPOLYSACCHARIDOSIS TYPE 1	0.0081413	0.4053898359581587
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0081413	0.4053898359581587
MULTIPLE SULFATASE DEFICIENCY	0.0081413	0.4053898359581587
FOCAL DERMAL HYPOPLASIA; FDH	0.00810718	0.40369085653191317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00810718	0.40369085653191317
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.007984880000000001	0.397601021132446
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.007984880000000001	0.397601021132446
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007984880000000001	0.397601021132446
CANAVAN DISEASE	0.007984880000000001	0.397601021132446
RETINITIS PIGMENTOSA	0.007984880000000001	0.397601021132446
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.007984880000000001	0.397601021132446
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.007984880000000001	0.397601021132446
CANAVAN DISEASE	0.007984880000000001	0.397601021132446
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.007984880000000001	0.397601021132446
KRABBE DISEASE	0.007984880000000001	0.397601021132446
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.007984880000000001	0.397601021132446
BANGSTAD SYNDROME	0.00774409	0.38561106638315956
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00748941	0.3729294696575968
FRIEDREICH ATAXIA	0.00745529	0.3712304902313513
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00745529	0.3712304902313513
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00745529	0.3712304902313513
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00745529	0.3712304902313513
MADRAS MOTOR NEURON DISEASE	0.00745529	0.3712304902313513
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00745529	0.3712304902313513
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00745529	0.3712304902313513
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.00745529	0.3712304902313513
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00745529	0.3712304902313513
PRIMARY HYPEROXALURIA	0.00745529	0.3712304902313513
IRVAN SYNDROME	0.00745529	0.3712304902313513
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00745529	0.3712304902313513
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0070922	0.3531507000825977
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0070922	0.3531507000825977
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0070922	0.3531507000825977
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.0070922	0.3531507000825977
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.0070922	0.3531507000825977
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0070922	0.3531507000825977
LARON SYNDROME	0.0070922	0.3531507000825977
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.0070922	0.3531507000825977
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.0070922	0.3531507000825977
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0070922	0.3531507000825977
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0070922	0.3531507000825977
OROFACIODIGITAL SYNDROME TYPE 4	0.0070922	0.3531507000825977
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0070922	0.3531507000825977
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0070922	0.3531507000825977
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.0070922	0.3531507000825977
LERI PLEONOSTEOSIS	0.0070922	0.3531507000825977
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.3531507000825977
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.0070922	0.3531507000825977
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0070922	0.3531507000825977
MIETENS SYNDROME	0.0070922	0.3531507000825977
SPONDYLOMETAPHYSEAL DYSPLASIA, A4 TYPE	0.0070922	0.3531507000825977
WEISMANN-NETTER SYNDROME	0.0070922	0.3531507000825977
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0070922	0.3531507000825977
BOOMERANG DYSPLASIA	0.0070922	0.3531507000825977
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.0070922	0.3531507000825977
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0070922	0.3531507000825977
EAR-PATELLA-SHORT STATURE SYNDROME	0.0070922	0.3531507000825977
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.0070922	0.3531507000825977
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0070922	0.3531507000825977
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.0070922	0.3531507000825977
RENPENNING SYNDROME	0.0070922	0.3531507000825977
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0070922	0.3531507000825977
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.0070922	0.3531507000825977
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.0070922	0.3531507000825977
ACHONDROGENESIS	0.0070922	0.3531507000825977
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.0070922	0.3531507000825977
SECKEL SYNDROME 10; SCKL10	0.0070922	0.3531507000825977
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0070922	0.3531507000825977
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0070922	0.3531507000825977
MARDEN-WALKER SYNDROME	0.0070922	0.3531507000825977
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0070922	0.3531507000825977
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0070922	0.3531507000825977
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0070922	0.3531507000825977
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0070922	0.3531507000825977
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0070922	0.3531507000825977
GERODERMA OSTEODYSPLASTICUM; GO	0.0070922	0.3531507000825977
ACROMICRIC DYSPLASIA	0.0070922	0.3531507000825977
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0070922	0.3531507000825977
MORQUIO SYNDROME C	0.0070922	0.3531507000825977
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0070922	0.3531507000825977
METATROPIC DYSPLASIA	0.0070922	0.3531507000825977
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.0070922	0.3531507000825977
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.0070922	0.3531507000825977
DE SANCTIS-CACCHIONE SYNDROME	0.0070922	0.3531507000825977
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0070922	0.3531507000825977
DWARFISM, LEVI TYPE	0.0070922	0.3531507000825977
IVIC SYNDROME	0.0070922	0.3531507000825977
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0070922	0.3531507000825977
MEIER-GORLIN SYNDROME 6; MGORS6	0.0070922	0.3531507000825977
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.3531507000825977
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0070922	0.3531507000825977
JOHNSON NEUROECTODERMAL SYNDROME	0.0070922	0.3531507000825977
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0070922	0.3531507000825977
RADIO-RENAL SYNDROME	0.0070922	0.3531507000825977
EVEN-PLUS SYNDROME	0.0070922	0.3531507000825977
TRYPTOPHANURIA WITH DWARFISM	0.0070922	0.3531507000825977
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0070922	0.3531507000825977
ACROMICRIC DYSPLASIA	0.0070922	0.3531507000825977
OLIVER-MCFARLANE SYNDROME	0.0070922	0.3531507000825977
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0070922	0.3531507000825977
INFANTILE SYSTEMIC HYALINOSIS	0.0070922	0.3531507000825977
DWARFISM WITH TALL VERTEBRAE	0.0070922	0.3531507000825977
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.0070922	0.3531507000825977
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0070922	0.3531507000825977
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.0070922	0.3531507000825977
LARON SYNDROME	0.0070922	0.3531507000825977
METATROPIC DYSPLASIA	0.0070922	0.3531507000825977
JUBERG-HAYWARD SYNDROME	0.0070922	0.3531507000825977
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0070922	0.3531507000825977
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0070922	0.3531507000825977
ACHONDROGENESIS TYPE 1A	0.0070922	0.3531507000825977
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.0070922	0.3531507000825977
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.0070922	0.3531507000825977
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0070922	0.3531507000825977
ALAZAMI SYNDROME; ALAZS	0.0070922	0.3531507000825977
SHORT SYNDROME	0.0070922	0.3531507000825977
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0070922	0.3531507000825977
DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	0.0070922	0.3531507000825977
SYNDESMODYSPLASIC DWARFISM	0.0070922	0.3531507000825977
CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS	0.0070922	0.3531507000825977
SECKEL SYNDROME 7; SCKL7	0.0070922	0.3531507000825977
ABLEPHARON MACROSTOMIA SYNDROME	0.006814199999999999	0.3393079017093197
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.006814199999999999	0.3393079017093197
GALACTOSEMIA	0.006814199999999999	0.3393079017093197
HEART AND BRAIN MALFORMATION SYNDROME	0.006814199999999999	0.3393079017093197
CHYLOMICRON RETENTION DISEASE	0.006814199999999999	0.3393079017093197
MOMO SYNDROME	0.0066759900000000014	0.3324258399712955
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0066759900000000014	0.3324258399712955
STICKLER SYNDROME	0.0066759900000000014	0.3324258399712955
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.0066759900000000014	0.3324258399712955
RENPENNING SYNDROME 1; RENS1	0.0066759900000000014	0.3324258399712955
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.0066759900000000014	0.3324258399712955
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0066759900000000014	0.3324258399712955
RODRIGUES BLINDNESS	0.0066759900000000014	0.3324258399712955
CONGENITAL RUBELLA SYNDROME	0.00618052	0.30775428849644637
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.0061464	0.30605530907020084
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0061464	0.30605530907020084
ISOLATED COMPLEX I DEFICIENCY	0.006024100000000001	0.2999654736707337
TEMPORAL ARTERITIS	0.006024100000000001	0.2999654736707337
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.2999654736707337
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.006024100000000001	0.2999654736707337
ALPERS-HUTTENLOCHER SYNDROME	0.006024100000000001	0.2999654736707337
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.006024100000000001	0.2999654736707337
LIGNEOUS CONJUNCTIVITIS	0.006024100000000001	0.2999654736707337
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.2999654736707337
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006024100000000001	0.2999654736707337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.006024100000000001	0.2999654736707337
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.2999654736707337
JOUBERT SYNDROME 6	0.006024100000000001	0.2999654736707337
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.2999654736707337
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.2999654736707337
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.2999654736707337
FRASER SYNDROME	0.006024100000000001	0.2999654736707337
CEREBROOCULONASAL SYNDROME	0.006024100000000001	0.2999654736707337
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.2999654736707337
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.006024100000000001	0.2999654736707337
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.2999654736707337
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.2999654736707337
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.2999654736707337
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.2999654736707337
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.2999654736707337
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.2999654736707337
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.2999654736707337
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.006024100000000001	0.2999654736707337
COGAN SYNDROME	0.006024100000000001	0.2999654736707337
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.006024100000000001	0.2999654736707337
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.2999654736707337
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.2999654736707337
XYLOSIDASE DEFICIENCY	0.006024100000000001	0.2999654736707337
MUSK, INABILITY TO SMELL	0.006024100000000001	0.2999654736707337
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.006024100000000001	0.2999654736707337
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.006024100000000001	0.2999654736707337
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.006024100000000001	0.2999654736707337
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.2999654736707337
VITREORETINOCHOROIDOPATHY; VRCP	0.006024100000000001	0.2999654736707337
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.2999654736707337
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.2999654736707337
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.006024100000000001	0.2999654736707337
FLECK RETINA OF KANDORI	0.006024100000000001	0.2999654736707337
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.2999654736707337
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.2999654736707337
HYDRANENCEPHALY	0.006024100000000001	0.2999654736707337
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.2999654736707337
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.006024100000000001	0.2999654736707337
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.2999654736707337
SANDHOFF DISEASE	0.006024100000000001	0.2999654736707337
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.2999654736707337
TAY-SACHS DISEASE; TSD	0.006024100000000001	0.2999654736707337
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.2999654736707337
ARIMA SYNDROME	0.006024100000000001	0.2999654736707337
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.2999654736707337
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.2999654736707337
GM2-GANGLIOSIDOSIS, AB VARIANT	0.006024100000000001	0.2999654736707337
WEBB-DATTANI SYNDROME; WEDAS	0.006024100000000001	0.2999654736707337
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.006024100000000001	0.2999654736707337
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.2999654736707337
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.2999654736707337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006024100000000001	0.2999654736707337
PIERSON SYNDROME	0.006024100000000001	0.2999654736707337
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.2999654736707337
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.2999654736707337
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.2999654736707337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.006024100000000001	0.2999654736707337
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.006024100000000001	0.2999654736707337
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.006024100000000001	0.2999654736707337
GLYCOGEN STORAGE DISEASE IXC	0.00601371	0.29944811153009204
HARDIKAR SYNDROME	0.00601371	0.29944811153009204
ZIMMERMANN-LABAND SYNDROME	0.00601371	0.29944811153009204
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00601371	0.29944811153009204
GALACTOSE EPIMERASE DEFICIENCY	0.00601371	0.29944811153009204
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00601371	0.29944811153009204
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00601371	0.29944811153009204
WOLMAN DISEASE	0.00601371	0.29944811153009204
HEREDITARY SPHEROCYTOSIS	0.00601371	0.29944811153009204
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00601371	0.29944811153009204
ALPHA-HEAVY CHAIN DISEASE	0.00601371	0.29944811153009204
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00601371	0.29944811153009204
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00601371	0.29944811153009204
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.0057772299999999995	0.2876727699498302
TRIPLE A SYNDROME	0.0057772299999999995	0.2876727699498302
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.0057772299999999995	0.2876727699498302
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0057772299999999995	0.2876727699498302
NEONATAL ADRENOLEUKODYSTROPHY	0.0057772299999999995	0.2876727699498302
GAPO SYNDROME	0.0057772299999999995	0.2876727699498302
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00561042	0.2793665929834759
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00561042	0.2793665929834759
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00561042	0.2793665929834759
FAMILIAL DYSAUTONOMIA	0.00561042	0.2793665929834759
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00561042	0.2793665929834759
GAPO SYNDROME; GAPOS	0.00561042	0.2793665929834759
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00561042	0.2793665929834759
ACROCALLOSAL SYNDROME; ACLS	0.00561042	0.2793665929834759
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00552863	0.2752939221958845
FISH-EYE DISEASE	0.00552863	0.2752939221958845
PROLIDASE DEFICIENCY	0.00552863	0.2752939221958845
TANGIER DISEASE; TGD	0.00552863	0.2752939221958845
EPISODIC ATAXIA TYPE 6	0.00549451	0.2735949427696391
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00549451	0.2735949427696391
KERATOCONUS 9; KTCN9	0.00549451	0.2735949427696391
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.00549451	0.2735949427696391
SPINOCEREBELLAR ATAXIA TYPE 25	0.00549451	0.2735949427696391
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00549451	0.2735949427696391
RETINOBLASTOMA	0.00549451	0.2735949427696391
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00549451	0.2735949427696391
STARGARDT DISEASE 3; STGD3	0.00549451	0.2735949427696391
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.2735949427696391
JOUBERT SYNDROME 30; JBTS30	0.00549451	0.2735949427696391
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00549451	0.2735949427696391
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.2735949427696391
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.2735949427696391
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00549451	0.2735949427696391
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.2735949427696391
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.2735949427696391
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.2735949427696391
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00549451	0.2735949427696391
MEGALOCORNEA	0.00549451	0.2735949427696391
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00549451	0.2735949427696391
ÅLAND ISLANDS EYE DISEASE	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.2735949427696391
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.2735949427696391
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.2735949427696391
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.2735949427696391
EDICT SYNDROME	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.2735949427696391
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.2735949427696391
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.2735949427696391
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00549451	0.2735949427696391
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00549451	0.2735949427696391
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.2735949427696391
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.2735949427696391
LEBER CONGENITAL AMAUROSIS 16	0.00549451	0.2735949427696391
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00549451	0.2735949427696391
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.2735949427696391
INTERMEDIATE UVEITIS	0.00549451	0.2735949427696391
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00549451	0.2735949427696391
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.2735949427696391
FOVEAL HYPOPLASIA 2; FVH2	0.00549451	0.2735949427696391
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.2735949427696391
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.00549451	0.2735949427696391
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00549451	0.2735949427696391
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.2735949427696391
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00549451	0.2735949427696391
NANOPHTHALMOS 4; NNO4	0.00549451	0.2735949427696391
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00549451	0.2735949427696391
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.2735949427696391
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.2735949427696391
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.2735949427696391
20P13 MICRODELETION SYNDROME	0.00549451	0.2735949427696391
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.2735949427696391
MICROPHTHALMIA, ISOLATED 5	0.00549451	0.2735949427696391
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.2735949427696391
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00549451	0.2735949427696391
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.2735949427696391
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.2735949427696391
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.2735949427696391
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00549451	0.2735949427696391
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00512534	0.2552124036492684
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00512534	0.2552124036492684
CRANIOTELENCEPHALIC DYSPLASIA	0.00512534	0.2552124036492684
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00512534	0.2552124036492684
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00512534	0.2552124036492684
FUMARASE DEFICIENCY; FMRD	0.00512534	0.2552124036492684
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00512534	0.2552124036492684
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512534	0.2552124036492684
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00512534	0.2552124036492684
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00512534	0.2552124036492684
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00512534	0.2552124036492684
JABERI-ELAHI SYNDROME; JABELS	0.00512534	0.2552124036492684
OCULODENTODIGITAL DYSPLASIA	0.00512534	0.2552124036492684
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00512534	0.2552124036492684
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00512534	0.2552124036492684
FILIPPI SYNDROME; FLPIS	0.00512534	0.2552124036492684
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00512534	0.2552124036492684
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00512534	0.2552124036492684
MUSCLE-EYE-BRAIN DISEASE	0.00512534	0.2552124036492684
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00512534	0.2552124036492684
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00512534	0.2552124036492684
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00512534	0.2552124036492684
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00512534	0.2552124036492684
JALILI SYNDROME	0.00512534	0.2552124036492684
INFANTILE NEUROAXONAL DYSTROPHY	0.00512534	0.2552124036492684
APERT SYNDROME	0.00512534	0.2552124036492684
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00512534	0.2552124036492684
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00512534	0.2552124036492684
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00512534	0.2552124036492684
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00512534	0.2552124036492684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00512534	0.2552124036492684
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00512534	0.2552124036492684
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00512534	0.2552124036492684
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00512534	0.2552124036492684
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00512534	0.2552124036492684
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00512534	0.2552124036492684
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00512534	0.2552124036492684
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00512534	0.2552124036492684
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00512534	0.2552124036492684
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00512534	0.2552124036492684
2P15P16.1 MICRODELETION SYNDROME	0.00512534	0.2552124036492684
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00512534	0.2552124036492684
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00512534	0.2552124036492684
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00512534	0.2552124036492684
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00512534	0.2552124036492684
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00512534	0.2552124036492684
CROUZON SYNDROME	0.00512534	0.2552124036492684
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00512534	0.2552124036492684
MUCKLE-WELLS SYNDROME	0.00497674	0.24781297977060252
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00432485	0.2153526134700407
COCKAYNE SYNDROME A; CSA	0.00432485	0.2153526134700407
CAMURATI-ENGELMANN DISEASE	0.00432485	0.2153526134700407
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00432485	0.2153526134700407
COMBINED SAPOSIN DEFICIENCY	0.00432485	0.2153526134700407
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.00432485	0.2153526134700407
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00432485	0.2153526134700407
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00430153	0.2141914118223254
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00430153	0.2141914118223254
SECKEL SYNDROME 2; SCKL2	0.00430153	0.2141914118223254
3MC SYNDROME 3	0.00430153	0.2141914118223254
GLYCEROL KINASE DEFICIENCY; GKD	0.00430153	0.2141914118223254
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00430153	0.2141914118223254
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00430153	0.2141914118223254
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00430153	0.2141914118223254
BONNEMANN-MEINECKE-REICH SYNDROME	0.00381645	0.1900372224881179
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00381645	0.1900372224881179
INCONTINENTIA PIGMENTI	0.00381645	0.1900372224881179
HELSMOORTEL-VAN DER AA SYNDROME	0.00381645	0.1900372224881179
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00381645	0.1900372224881179
COFFIN-SIRIS SYNDROME 2; CSS2	0.00381645	0.1900372224881179
OSTEOGENESIS IMPERFECTA	0.00381645	0.1900372224881179
VOGT-KOYANAGI-HARADA DISEASE	0.00381645	0.1900372224881179
COFFIN-SIRIS SYNDROME 3; CSS3	0.00381645	0.1900372224881179
FETAL METHYLMERCURY SYNDROME	0.00381645	0.1900372224881179
COFFIN-SIRIS SYNDROME 4; CSS4	0.00381645	0.1900372224881179
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00381645	0.1900372224881179
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00381645	0.1900372224881179
FANCONI ANEMIA	0.00381645	0.1900372224881179
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00381645	0.1900372224881179
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00381645	0.1900372224881179
CYSTINOSIS	0.00381645	0.1900372224881179
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00381645	0.1900372224881179
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00381645	0.1900372224881179
AYMÉ-GRIPP SYNDROME	0.00381645	0.1900372224881179
RFT1-CDG	0.00381645	0.1900372224881179
FOUNTAIN SYNDROME	0.00381645	0.1900372224881179
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00381645	0.1900372224881179
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00381645	0.1900372224881179
MICROPHTHALMIA, LENZ TYPE	0.00381645	0.1900372224881179
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00381645	0.1900372224881179
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00381645	0.1900372224881179
WAGR SYNDROME	0.00381645	0.1900372224881179
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00381645	0.1900372224881179
MUCOLIPIDOSIS TYPE III	0.00381645	0.1900372224881179
WILLIAMS SYNDROME	0.00381645	0.1900372224881179
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00381645	0.1900372224881179
GOLDENHAR SYNDROME	0.00381645	0.1900372224881179
LOWRY-WOOD SYNDROME	0.00381645	0.1900372224881179
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00381645	0.1900372224881179
BUSCHKE-OLLENDORFF SYNDROME	0.00381645	0.1900372224881179
COFFIN-SIRIS SYNDROME 1; CSS1	0.00381645	0.1900372224881179
ACRODERMATITIS ENTEROPATHICA	0.00381645	0.1900372224881179
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00381645	0.1900372224881179
PRADER-WILLI-LIKE SYNDROME	0.00381645	0.1900372224881179
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00381645	0.1900372224881179
2P21 MICRODELETION SYNDROME	0.00364964	0.1817310455217636
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.00364964	0.1817310455217636
CERNUNNOS-XLF DEFICIENCY	0.00364964	0.1817310455217636
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.00364964	0.1817310455217636
RING CHROMOSOME 22 SYNDROME	0.00364964	0.1817310455217636
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.1817310455217636
RING CHROMOSOME 13 SYNDROME	0.00364964	0.1817310455217636
LYSINE MALABSORPTION SYNDROME	0.00364964	0.1817310455217636
BARTH SYNDROME; BTHS	0.00364964	0.1817310455217636
DUPLICATION/INVERSION 15Q11	0.00364964	0.1817310455217636
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00364964	0.1817310455217636
NEPHRONOPHTHISIS 1	0.00364964	0.1817310455217636
SERKAL SYNDROME	0.00364964	0.1817310455217636
LIG4 SYNDROME	0.00364964	0.1817310455217636
CITRULLINE TRANSPORT DEFECT	0.00364964	0.1817310455217636
NEPHRONOPHTHISIS 11; NPHP11	0.00364964	0.1817310455217636
CHYLOMICRON RETENTION DISEASE	0.00364964	0.1817310455217636
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	0.1817310455217636
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	0.1817310455217636
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00364964	0.1817310455217636
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.1817310455217636
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.1817310455217636
MONOSOMY 13Q34	0.00364964	0.1817310455217636
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00364964	0.1817310455217636
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00364964	0.1817310455217636
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	0.1817310455217636
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00364964	0.1817310455217636
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00364964	0.1817310455217636
CYCLIC VOMITING SYNDROME	0.00364964	0.1817310455217636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00364964	0.1817310455217636
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.00364964	0.1817310455217636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.1817310455217636
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.1817310455217636
JOUBERT SYNDROME 14	0.00364964	0.1817310455217636
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.1817310455217636
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00364964	0.1817310455217636
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00364964	0.1817310455217636
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00364964	0.1817310455217636
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.1817310455217636
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.1817310455217636
FAMILIAL HYPOALDOSTERONISM	0.00364964	0.1817310455217636
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00364964	0.1817310455217636
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.1817310455217636
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	0.1817310455217636
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00364964	0.1817310455217636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.1817310455217636
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00364964	0.1817310455217636
NATHALIE SYNDROME	0.00364964	0.1817310455217636
X SMALL RINGS	0.00364964	0.1817310455217636
FRANK-TER HAAR SYNDROME; FTHS	0.00364964	0.1817310455217636
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00364964	0.1817310455217636
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.00364964	0.1817310455217636
SENGERS SYNDROME	0.00364964	0.1817310455217636
3MC SYNDROME 1	0.00364964	0.1817310455217636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.1817310455217636
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	0.1817310455217636
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00364964	0.1817310455217636
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.1817310455217636
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.1817310455217636
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	0.1817310455217636
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00364964	0.1817310455217636
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00364964	0.1817310455217636
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	0.1817310455217636
T-SUBSTANCE ANOMALY	0.00364964	0.1817310455217636
COG4-CDG	0.00364964	0.1817310455217636
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00364964	0.1817310455217636
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.1817310455217636
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.1817310455217636
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.1817310455217636
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.1817310455217636
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00364964	0.1817310455217636
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	0.1817310455217636
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00364964	0.1817310455217636
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00364964	0.1817310455217636
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.1817310455217636
THREONINEMIA	0.00364964	0.1817310455217636
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00364964	0.1817310455217636
RING CHROMOSOME 14 SYNDROME	0.00364964	0.1817310455217636
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00364964	0.1817310455217636
CLASSIC PHENYLKETONURIA	0.00364964	0.1817310455217636
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00364964	0.1817310455217636
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00364964	0.1817310455217636
ADENYLOSUCCINASE DEFICIENCY	0.00364964	0.1817310455217636
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	0.1817310455217636
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00364964	0.1817310455217636
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00364964	0.1817310455217636
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00364964	0.1817310455217636
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00364964	0.1817310455217636
JOUBERT SYNDROME 10	0.00364964	0.1817310455217636
XP21 MICRODELETION SYNDROME	0.00364964	0.1817310455217636
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.1817310455217636
LATHOSTEROLOSIS	0.00364964	0.1817310455217636
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.1817310455217636
CINCA SYNDROME; CINCA	0.00364964	0.1817310455217636
AROMATASE DEFICIENCY	0.00364964	0.1817310455217636
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00364964	0.1817310455217636
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00364964	0.1817310455217636
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00364964	0.1817310455217636
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00364964	0.1817310455217636
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00364964	0.1817310455217636
NEPHRONOPHTHISIS 4	0.00364964	0.1817310455217636
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00364964	0.1817310455217636
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.1817310455217636
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.1817310455217636
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	0.1817310455217636
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	0.1817310455217636
KLEEFSTRA SYNDROME 2; KLEFS2	0.00364964	0.1817310455217636
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00364964	0.1817310455217636
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.1817310455217636
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.1817310455217636
14Q12 MICRODELETION SYNDROME	0.00364964	0.1817310455217636
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00364964	0.1817310455217636
CRYPTOSPORIDIOSIS	0.00364964	0.1817310455217636
CUSHING SYNDROME	0.00364964	0.1817310455217636
20Q13.33 MICRODELETION SYNDROME	0.00364964	0.1817310455217636
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	0.1817310455217636
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00364964	0.1817310455217636
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.1817310455217636
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00364964	0.1817310455217636
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00364964	0.1817310455217636
RING CHROMOSOME 12 SYNDROME	0.00364964	0.1817310455217636
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00364964	0.1817310455217636
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00364964	0.1817310455217636
CHROMOSOME 5Q12 DELETION SYNDROME	0.00364964	0.1817310455217636
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00364964	0.1817310455217636
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00364964	0.1817310455217636
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.1817310455217636
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00364964	0.1817310455217636
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00364964	0.1817310455217636
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00364964	0.1817310455217636
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00364964	0.1817310455217636
THYROID HEMIAGENESIS	0.00364964	0.1817310455217636
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.1817310455217636
HEREDITARY FRUCTOSE INTOLERANCE	0.00364964	0.1817310455217636
SALLA DISEASE	0.00364964	0.1817310455217636
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00364964	0.1817310455217636
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00364964	0.1817310455217636
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00364964	0.1817310455217636
MEHMO SYNDROME	0.00364964	0.1817310455217636
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.1817310455217636
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.00364964	0.1817310455217636
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.1817310455217636
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	0.1817310455217636
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.00364964	0.1817310455217636
HYPOTONIA-CYSTINURIA SYNDROME	0.00364964	0.1817310455217636
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00364964	0.1817310455217636
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.1817310455217636
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00364964	0.1817310455217636
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.1817310455217636
JUVENILE POLYPOSIS SYNDROME	0.00364964	0.1817310455217636
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.1817310455217636
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00364964	0.1817310455217636
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.00364964	0.1817310455217636
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00364964	0.1817310455217636
ROWLEY-ROSENBERG SYNDROME	0.00364964	0.1817310455217636
VICI SYNDROME; VICIS	0.00364964	0.1817310455217636
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	0.1817310455217636
MAJEED SYNDROME	0.00364964	0.1817310455217636
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00364964	0.1817310455217636
SECONDARY SHORT BOWEL SYNDROME	0.00364964	0.1817310455217636
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.1817310455217636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00364964	0.1817310455217636
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.1817310455217636
2Q24 MICRODELETION SYNDROME	0.00364964	0.1817310455217636
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.1817310455217636
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.1817310455217636
AXENFELD-RIEGER SYNDROME	0.00364964	0.1817310455217636
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.1817310455217636
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00364964	0.1817310455217636
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00364964	0.1817310455217636
OCULOECTODERMAL SYNDROME; OES	0.00364964	0.1817310455217636
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00364964	0.1817310455217636
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00364964	0.1817310455217636
STEVENS-JOHNSON SYNDROME	0.00316456	0.1575768561875561
BLUE CONE MONOCHROMATISM	0.00316456	0.1575768561875561
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.1575768561875561
ERDHEIM-CHESTER DISEASE	0.00316456	0.1575768561875561
GILLESPIE SYNDROME; GLSP	0.00316456	0.1575768561875561
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.1575768561875561
ALBINISM, OCULAR, TYPE I	0.00316456	0.1575768561875561
MMEP SYNDROME	0.00316456	0.1575768561875561
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.1575768561875561
KALLMANN SYNDROME	0.00316456	0.1575768561875561
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.1575768561875561
KRABBE DISEASE	0.00316456	0.1575768561875561
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.1575768561875561
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00316456	0.1575768561875561
UNILATERAL POLYMICROGYRIA	0.00316456	0.1575768561875561
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.1575768561875561
MOEBIUS SYNDROME	0.00316456	0.1575768561875561
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00316456	0.1575768561875561
MARFAN SYNDROME	0.00316456	0.1575768561875561
OCULOCUTANEOUS ALBINISM	0.00316456	0.1575768561875561
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.1575768561875561
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.1575768561875561
N SYNDROME	0.00316456	0.1575768561875561
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.1575768561875561
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.1575768561875561
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.1575768561875561
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.1575768561875561
MALT LYMPHOMA	0.00316456	0.1575768561875561
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00316456	0.1575768561875561
OCULAR ALBINISM	0.00316456	0.1575768561875561
BRADYOPSIA	0.00316456	0.1575768561875561
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.1575768561875561
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.1575768561875561
N SYNDROME	0.00316456	0.1575768561875561
X-LINKED RETINAL DYSPLASIA	0.00316456	0.1575768561875561
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.1575768561875561
CONE ROD DYSTROPHY	0.00316456	0.1575768561875561
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00316456	0.1575768561875561
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.1575768561875561
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.1575768561875561
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.1575768561875561
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.1575768561875561
FLYNN-AIRD SYNDROME	0.00316456	0.1575768561875561
2Q23.1 MICRODUPLICATION SYNDROME	0.00316456	0.1575768561875561
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.1575768561875561
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.1575768561875561
MANGANESE POISONING	0.00316456	0.1575768561875561
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.1575768561875561
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00316456	0.1575768561875561
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.1575768561875561
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.1575768561875561
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00316456	0.1575768561875561
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.1575768561875561
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.1575768561875561
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00316456	0.1575768561875561
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00316456	0.1575768561875561
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00316456	0.1575768561875561
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00316456	0.1575768561875561
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00316456	0.1575768561875561
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.1575768561875561
ASCHER SYNDROME	0.00316456	0.1575768561875561
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00316456	0.1575768561875561
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.1575768561875561
TREACHER-COLLINS SYNDROME	0.00316456	0.1575768561875561
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.1575768561875561
CADASIL	0.00316456	0.1575768561875561
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.1575768561875561
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.1575768561875561
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.1575768561875561
SCHINZEL-GIEDION SYNDROME	0.00316456	0.1575768561875561
BROOKE-SPIEGLER SYNDROME	0.00316456	0.1575768561875561
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.1575768561875561
ABETALIPOPROTEINEMIA	0.00316456	0.1575768561875561
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00316456	0.1575768561875561
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.1575768561875561
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.1575768561875561
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.1575768561875561
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.1575768561875561
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00316456	0.1575768561875561
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.1575768561875561
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.1575768561875561
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.1575768561875561
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.1575768561875561
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.1575768561875561
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.1575768561875561
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.1575768561875561
PEROXISOME BIOGENESIS DISORDER 6B	0.00316456	0.1575768561875561
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.1575768561875561
PEROXISOME BIOGENESIS DISORDER 5B	0.00316456	0.1575768561875561
BAKER-GORDON SYNDROME; BAGOS	0.00316456	0.1575768561875561
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00316456	0.1575768561875561
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.1575768561875561
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.1575768561875561
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00316456	0.1575768561875561
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00316456	0.1575768561875561
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.1575768561875561
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.1575768561875561
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.1575768561875561
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.1575768561875561
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.1575768561875561
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.1575768561875561
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.1575768561875561
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.1575768561875561
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.1575768561875561
JOUBERT SYNDROME 2	0.00316456	0.1575768561875561
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.1575768561875561
RENAL COLOBOMA SYNDROME	0.00316456	0.1575768561875561
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.1575768561875561
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00301596	0.15017743230889025
DYSKERATOSIS CONGENITA	0.00301596	0.15017743230889025
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00301596	0.15017743230889025
HURLER-SCHEIE SYNDROME	0.00301596	0.15017743230889025
NIEMANN-PICK DISEASE TYPE B	0.00301596	0.15017743230889025
HURLER-SCHEIE SYNDROME	0.00301596	0.15017743230889025
NIEMANN-PICK DISEASE, TYPE B	0.00301596	0.15017743230889025
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00301596	0.15017743230889025
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00301596	0.15017743230889025
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00301596	0.15017743230889025
NIEMANN-PICK DISEASE, TYPE A	0.00301596	0.15017743230889025
SIALIDOSIS TYPE 2	0.00301596	0.15017743230889025
HURLER SYNDROME	0.00301596	0.15017743230889025
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00301596	0.15017743230889025
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00301596	0.15017743230889025
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00301596	0.15017743230889025
MEVALONIC ACIDURIA	0.00301596	0.15017743230889025
LYMPHEDEMA, HEREDITARY, III	0.00301596	0.15017743230889025
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00301596	0.15017743230889025
IMMUNODEFICIENCY 36; IMD36	0.00301596	0.15017743230889025
AREDYLD SYNDROME	0.00301596	0.15017743230889025
SYNDROMIC DIARRHEA	0.00301596	0.15017743230889025
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00301596	0.15017743230889025
ACROOSTEOLYSIS DOMINANT TYPE	0.00301596	0.15017743230889025
8P11.2 DELETION SYNDROME	0.00301596	0.15017743230889025
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00301596	0.15017743230889025
PYCNODYSOSTOSIS	0.00301596	0.15017743230889025
GAUCHER DISEASE	0.00301596	0.15017743230889025
HURLER SYNDROME	0.00301596	0.15017743230889025
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00301596	0.15017743230889025
GRISCELLI SYNDROME	0.00301596	0.15017743230889025
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00301596	0.15017743230889025
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00301596	0.15017743230889025
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00301596	0.15017743230889025
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00301596	0.15017743230889025
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00301596	0.15017743230889025
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00301596	0.15017743230889025
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00261267	0.13009591376227414
CRANIODIAPHYSEAL DYSPLASIA	0.00261267	0.13009591376227414
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00261267	0.13009591376227414
VICI SYNDROME	0.00261267	0.13009591376227414
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00261267	0.13009591376227414
CORNELIA DE LANGE SYNDROME 1	0.00261267	0.13009591376227414
INCONTINENTIA PIGMENTI; IP	0.00261267	0.13009591376227414
COHEN SYNDROME	0.00261267	0.13009591376227414
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00261267	0.13009591376227414
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00261267	0.13009591376227414
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00261267	0.13009591376227414
KEUTEL SYNDROME	0.00261267	0.13009591376227414
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00261267	0.13009591376227414
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00261267	0.13009591376227414
COFFIN-LOWRY SYNDROME	0.00261267	0.13009591376227414
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00261267	0.13009591376227414
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00261267	0.13009591376227414
SPINOCEREBELLAR ATAXIA TYPE 13	0.00261267	0.13009591376227414
XERODERMA PIGMENTOSUM	0.00261267	0.13009591376227414
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00261267	0.13009591376227414
MERRF	0.00261267	0.13009591376227414
CHOPS SYNDROME; CHOPS	0.00261267	0.13009591376227414
SAY-BARBER-MILLER SYNDROME	0.00261267	0.13009591376227414
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00261267	0.13009591376227414
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00261267	0.13009591376227414
DYSOSTEOSCLEROSIS	0.00261267	0.13009591376227414
WARBURG MICRO SYNDROME 1	0.00261267	0.13009591376227414
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00261267	0.13009591376227414
DISTAL MONOSOMY 13Q	0.00261267	0.13009591376227414
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00261267	0.13009591376227414
3C SYNDROME	0.00261267	0.13009591376227414
JUVENILE PAGET DISEASE	0.00261267	0.13009591376227414
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00261267	0.13009591376227414
FABRY DISEASE	0.00261267	0.13009591376227414
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00261267	0.13009591376227414
PELIZAEUS-MERZBACHER DISEASE	0.00261267	0.13009591376227414
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00261267	0.13009591376227414
COCKAYNE SYNDROME	0.00261267	0.13009591376227414
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00261267	0.13009591376227414
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00236407	0.1177170660083284
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00236407	0.1177170660083284
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.00236407	0.1177170660083284
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00236407	0.1177170660083284
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00236407	0.1177170660083284
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00236407	0.1177170660083284
GLYCOPROTEIN STORAGE DISEASE	0.00236407	0.1177170660083284
GLYCOGEN STORAGE DISEASE II	0.00236407	0.1177170660083284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00236407	0.1177170660083284
PROTEUS-LIKE SYNDROME	0.00236407	0.1177170660083284
ISOLATED BILIARY ATRESIA	0.00236407	0.1177170660083284
BETA-THALASSEMIA INTERMEDIA	0.00236407	0.1177170660083284
HEREDITARY OROTIC ACIDURIA	0.00236407	0.1177170660083284
ALPHA-MANNOSIDOSIS	0.00236407	0.1177170660083284
PORTAL HYPERTENSION, NONCIRRHOTIC	0.00236407	0.1177170660083284
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00236407	0.1177170660083284
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00236407	0.1177170660083284
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00236407	0.1177170660083284
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00236407	0.1177170660083284
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00236407	0.1177170660083284
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00236407	0.1177170660083284
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 16	0.00236407	0.1177170660083284
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 47	0.00236407	0.1177170660083284
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.00236407	0.1177170660083284
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00236407	0.1177170660083284
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00236407	0.1177170660083284
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00236407	0.1177170660083284
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00236407	0.1177170660083284
MACROCEPHALY/AUTISM SYNDROME	0.00236407	0.1177170660083284
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00236407	0.1177170660083284
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00236407	0.1177170660083284
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.00236407	0.1177170660083284
TYROSINEMIA TYPE 1	0.00236407	0.1177170660083284
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.00236407	0.1177170660083284
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00236407	0.1177170660083284
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00236407	0.1177170660083284
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00236407	0.1177170660083284
MULTIPLE MYELOMA	0.00236407	0.1177170660083284
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00236407	0.1177170660083284
HYPERLIPOPROTEINEMIA, TYPE I	0.00236407	0.1177170660083284
DK1-CDG	0.00236407	0.1177170660083284
GALACTOSE EPIMERASE DEFICIENCY	0.00236407	0.1177170660083284
KIKUCHI-FUJIMOTO DISEASE	0.00236407	0.1177170660083284
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.00236407	0.1177170660083284
PACHYDERMOPERIOSTOSIS	0.00236407	0.1177170660083284
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00236407	0.1177170660083284
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00236407	0.1177170660083284
HEMOGLOBIN--BETA LOCUS	0.00236407	0.1177170660083284
SPLENOPORTAL VASCULAR ANOMALIES	0.00236407	0.1177170660083284
PRIMARY LIPODYSTROPHY	0.00236407	0.1177170660083284
CHRONIC MYELOID LEUKEMIA	0.00236407	0.1177170660083284
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00236407	0.1177170660083284
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00236407	0.1177170660083284
MANTLE CELL LYMPHOMA	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 52; IMD52	0.00236407	0.1177170660083284
GAUCHER DISEASE, TYPE II	0.00236407	0.1177170660083284
GAUCHER DISEASE, TYPE IIIC	0.00236407	0.1177170660083284
CRYOGLOBULINEMIC VASCULITIS	0.00236407	0.1177170660083284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00236407	0.1177170660083284
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00236407	0.1177170660083284
JUVENILE IDIOPATHIC ARTHRITIS	0.00236407	0.1177170660083284
OKAMOTO SYNDROME	0.00236407	0.1177170660083284
SPHEROCYTOSIS, TYPE 2	0.00236407	0.1177170660083284
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00236407	0.1177170660083284
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00236407	0.1177170660083284
SCLEROSING CHOLANGITIS, NEONATAL	0.00236407	0.1177170660083284
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00236407	0.1177170660083284
LEISHMANIASIS	0.00236407	0.1177170660083284
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00236407	0.1177170660083284
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00236407	0.1177170660083284
SCHEIE SYNDROME	0.00236407	0.1177170660083284
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00236407	0.1177170660083284
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00236407	0.1177170660083284
NIEMANN-PICK DISEASE, TYPE C2	0.00236407	0.1177170660083284
FELTY SYNDROME	0.00236407	0.1177170660083284
COLD AGGLUTININ DISEASE	0.00236407	0.1177170660083284
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00236407	0.1177170660083284
FOLLICULAR LYMPHOMA	0.00236407	0.1177170660083284
ASPARTYLGLUCOSAMINURIA	0.00236407	0.1177170660083284
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00236407	0.1177170660083284
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00236407	0.1177170660083284
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00236407	0.1177170660083284
ADAMS-OLIVER SYNDROME 5; AOS5	0.00236407	0.1177170660083284
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00236407	0.1177170660083284
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00236407	0.1177170660083284
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00236407	0.1177170660083284
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00236407	0.1177170660083284
CRONKHITE-CANADA SYNDROME	0.00236407	0.1177170660083284
HYPERLIPOPROTEINEMIA, TYPE ID	0.00236407	0.1177170660083284
TYROSINEMIA, TYPE I; TYRSN1	0.00236407	0.1177170660083284
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00236407	0.1177170660083284
AICARDI-GOUTIERES SYNDROME 7	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 32B; IMD32B	0.00236407	0.1177170660083284
HEREDITARY ELLIPTOCYTOSIS	0.00236407	0.1177170660083284
HEMOCHROMATOSIS, TYPE 1	0.00236407	0.1177170660083284
FAMILIAL TUMORAL CALCINOSIS	0.00236407	0.1177170660083284
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00236407	0.1177170660083284
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00236407	0.1177170660083284
NEPHRONOPHTHISIS 19; NPHP19	0.00236407	0.1177170660083284
FELTY SYNDROME	0.00236407	0.1177170660083284
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00236407	0.1177170660083284
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00236407	0.1177170660083284
CLASSIC MYCOSIS FUNGOIDES	0.00236407	0.1177170660083284
ATAXIA-PANCYTOPENIA SYNDROME	0.00236407	0.1177170660083284
WILSON DISEASE	0.00236407	0.1177170660083284
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00236407	0.1177170660083284
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00236407	0.1177170660083284
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00236407	0.1177170660083284
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00236407	0.1177170660083284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00236407	0.1177170660083284
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00236407	0.1177170660083284
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.00236407	0.1177170660083284
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00236407	0.1177170660083284
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.00236407	0.1177170660083284
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.00236407	0.1177170660083284
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00236407	0.1177170660083284
SPHEROCYTOSIS, TYPE 1; SPH1	0.00236407	0.1177170660083284
PRIMARY MYELOFIBROSIS	0.00236407	0.1177170660083284
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00236407	0.1177170660083284
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.00236407	0.1177170660083284
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00236407	0.1177170660083284
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00236407	0.1177170660083284
OMENN SYNDROME	0.00236407	0.1177170660083284
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00236407	0.1177170660083284
TRIMETHYLAMINURIA	0.00236407	0.1177170660083284
ADULT-ONSET STILL DISEASE	0.00236407	0.1177170660083284
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00236407	0.1177170660083284
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00236407	0.1177170660083284
SCRUB TYPHUS	0.00236407	0.1177170660083284
FREE SIALIC ACID STORAGE DISEASE	0.00236407	0.1177170660083284
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00236407	0.1177170660083284
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00236407	0.1177170660083284
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00236407	0.1177170660083284
HEMOCHROMATOSIS, TYPE 2A	0.00236407	0.1177170660083284
CHRONIC GRANULOMATOUS DISEASE	0.00236407	0.1177170660083284
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00236407	0.1177170660083284
GAUCHER DISEASE TYPE 1	0.00236407	0.1177170660083284
GAUCHER DISEASE TYPE 2	0.00236407	0.1177170660083284
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00236407	0.1177170660083284
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.00236407	0.1177170660083284
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.00236407	0.1177170660083284
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00236407	0.1177170660083284
GAUCHER DISEASE TYPE 3	0.00236407	0.1177170660083284
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00236407	0.1177170660083284
REYNOLDS SYNDROME	0.00236407	0.1177170660083284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00236407	0.1177170660083284
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00236407	0.1177170660083284
CHOLESTERYL ESTER STORAGE DISEASE	0.00236407	0.1177170660083284
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00236407	0.1177170660083284
PROTEUS SYNDROME	0.00236407	0.1177170660083284
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00236407	0.1177170660083284
SITOSTEROLEMIA	0.00236407	0.1177170660083284
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00236407	0.1177170660083284
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00236407	0.1177170660083284
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00236407	0.1177170660083284
AMERICAN TRYPANOSOMIASIS	0.00236407	0.1177170660083284
X-LINKED SIDEROBLASTIC ANEMIA	0.00236407	0.1177170660083284
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00236407	0.1177170660083284
POLYCYTHEMIA VERA	0.00236407	0.1177170660083284
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00236407	0.1177170660083284
PRIMARY SCLEROSING CHOLANGITIS	0.00236407	0.1177170660083284
BUDD-CHIARI SYNDROME	0.00236407	0.1177170660083284
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00236407	0.1177170660083284
HEMOCHROMATOSIS, TYPE 2B	0.00236407	0.1177170660083284
ELLIPTOCYTOSIS 1; EL1	0.00236407	0.1177170660083284
TYPHOID	0.00236407	0.1177170660083284
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00236407	0.1177170660083284
WALDENSTRÖM MACROGLOBULINEMIA	0.00236407	0.1177170660083284
GRAY PLATELET SYNDROME	0.00236407	0.1177170660083284
SEVERE COMBINED IMMUNODEFICIENCY	0.00236407	0.1177170660083284
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00236407	0.1177170660083284
SCHNITZLER SYNDROME	0.00236407	0.1177170660083284
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00236407	0.1177170660083284
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00236407	0.1177170660083284
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00236407	0.1177170660083284
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00236407	0.1177170660083284
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00236407	0.1177170660083284
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00236407	0.1177170660083284
GAMMA-HEAVY CHAIN DISEASE	0.00236407	0.1177170660083284
MU-HEAVY CHAIN DISEASE	0.00236407	0.1177170660083284
NIEMANN-PICK DISEASE TYPE C	0.00236407	0.1177170660083284
HENNEKAM SYNDROME	0.00236407	0.1177170660083284
AUTOIMMUNE HEPATITIS	0.00236407	0.1177170660083284
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.00236407	0.1177170660083284
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00236407	0.1177170660083284
NAKAJO-NISHIMURA SYNDROME	0.00236407	0.1177170660083284
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00236407	0.1177170660083284
HYPER-IGD SYNDROME	0.00236407	0.1177170660083284
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00236407	0.1177170660083284
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00236407	0.1177170660083284
SEA-BLUE HISTIOCYTOSIS	0.00236407	0.1177170660083284
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00236407	0.1177170660083284
COMMON VARIABLE IMMUNODEFICIENCY	0.00236407	0.1177170660083284
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00236407	0.1177170660083284
IMMUNODEFICIENCY 60; IMD60	0.00236407	0.1177170660083284
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00236407	0.1177170660083284
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00236407	0.1177170660083284
PROTEUS SYNDROME	0.00236407	0.1177170660083284
FETAL GAUCHER DISEASE	0.00236407	0.1177170660083284
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00236407	0.1177170660083284
GRISCELLI SYNDROME TYPE 2	0.00236407	0.1177170660083284
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00236407	0.1177170660083284
MAST CELL SARCOMA	0.00236407	0.1177170660083284
PFAPA SYNDROME	0.00236407	0.1177170660083284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.00236407	0.1177170660083284
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00236407	0.1177170660083284
APOLIPOPROTEIN C-II DEFICIENCY	0.00236407	0.1177170660083284
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00236407	0.1177170660083284
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00236407	0.1177170660083284
SÉZARY SYNDROME	0.00236407	0.1177170660083284
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00236407	0.1177170660083284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.00236407	0.1177170660083284
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00236407	0.1177170660083284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00236407	0.1177170660083284
BABESIOSIS	0.00236407	0.1177170660083284
APOLIPOPROTEIN A-I DEFICIENCY	0.00236407	0.1177170660083284
SICKLE CELL ANEMIA	0.00236407	0.1177170660083284
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00236407	0.1177170660083284
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00236407	0.1177170660083284
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00236407	0.1177170660083284
MAJEED SYNDROME	0.00236407	0.1177170660083284
WOLFRAM SYNDROME	0.00196078	0.0976355474617123
AMISH LETHAL MICROCEPHALY	0.00196078	0.0976355474617123
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00196078	0.0976355474617123
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00196078	0.0976355474617123
ROIFMAN-CHITAYAT SYNDROME	0.00196078	0.0976355474617123
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00196078	0.0976355474617123
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00196078	0.0976355474617123
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00196078	0.0976355474617123
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.00196078	0.0976355474617123
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00196078	0.0976355474617123
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00196078	0.0976355474617123
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00196078	0.0976355474617123
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.00196078	0.0976355474617123
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.00196078	0.0976355474617123
19P13.13 MICRODELETION SYNDROME	0.00196078	0.0976355474617123
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00196078	0.0976355474617123
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00196078	0.0976355474617123
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00196078	0.0976355474617123
LAMB-SHAFFER SYNDROME	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00196078	0.0976355474617123
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00196078	0.0976355474617123
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00196078	0.0976355474617123
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00196078	0.0976355474617123
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00196078	0.0976355474617123
METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY	0.00196078	0.0976355474617123
WOLFRAM-LIKE SYNDROME	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00196078	0.0976355474617123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.00196078	0.0976355474617123
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00196078	0.0976355474617123
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.00196078	0.0976355474617123
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00196078	0.0976355474617123
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00196078	0.0976355474617123
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00196078	0.0976355474617123
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00196078	0.0976355474617123
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00196078	0.0976355474617123
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.00196078	0.0976355474617123
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00196078	0.0976355474617123
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00196078	0.0976355474617123
SCLEROSTEOSIS	0.00196078	0.0976355474617123
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00196078	0.0976355474617123
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00196078	0.0976355474617123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.00196078	0.0976355474617123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.00196078	0.0976355474617123
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00196078	0.0976355474617123
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00196078	0.0976355474617123
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00196078	0.0976355474617123
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.00196078	0.0976355474617123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00196078	0.0976355474617123
PEHO SYNDROME; PEHO	0.00196078	0.0976355474617123
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00196078	0.0976355474617123
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00196078	0.0976355474617123
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00196078	0.0976355474617123
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00196078	0.0976355474617123
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00196078	0.0976355474617123
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00196078	0.0976355474617123
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00196078	0.0976355474617123
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00196078	0.0976355474617123
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00196078	0.0976355474617123
WARBURG MICRO SYNDROME 2; WARBM2	0.00196078	0.0976355474617123
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00196078	0.0976355474617123
WOLF-HIRSCHHORN SYNDROME	0.00196078	0.0976355474617123
METACHROMATIC LEUKODYSTROPHY	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA TYPE 2	0.00196078	0.0976355474617123
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00196078	0.0976355474617123
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00196078	0.0976355474617123
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA TYPE 7	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00196078	0.0976355474617123
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00196078	0.0976355474617123
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00196078	0.0976355474617123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00196078	0.0976355474617123
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00196078	0.0976355474617123
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.00196078	0.0976355474617123
LEIGH SYNDROME; LS	0.00196078	0.0976355474617123
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00196078	0.0976355474617123
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.00196078	0.0976355474617123
LISSENCEPHALY 5; LIS5	0.00196078	0.0976355474617123
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00196078	0.0976355474617123
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00196078	0.0976355474617123
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.00196078	0.0976355474617123
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00196078	0.0976355474617123
SPINOCEREBELLAR ATAXIA TYPE 1	0.00196078	0.0976355474617123
TARP SYNDROME	0.00196078	0.0976355474617123
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00196078	0.0976355474617123
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00196078	0.0976355474617123
ADAMS-OLIVER SYNDROME 2; AOS2	0.00196078	0.0976355474617123
WARBURG MICRO SYNDROME 3; WARBM3	0.00196078	0.0976355474617123
NEUROFERRITINOPATHY	0.00196078	0.0976355474617123
HAREL-YOON SYNDROME; HAYOS	0.00196078	0.0976355474617123
STT3B-CDG	0.00196078	0.0976355474617123
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00196078	0.0976355474617123
PEHO-LIKE SYNDROME; PEHOL	0.00196078	0.0976355474617123
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00196078	0.0976355474617123
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00196078	0.0976355474617123
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00196078	0.0976355474617123
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00196078	0.0976355474617123
DOORS SYNDROME	0.00196078	0.0976355474617123
METACHROMATIC LEUKODYSTROPHY	0.00196078	0.0976355474617123
OPTIC ATROPHY 2	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00196078	0.0976355474617123
OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME	0.00196078	0.0976355474617123
AICARDI SYNDROME; AIC	0.00196078	0.0976355474617123
TARP SYNDROME; TARPS	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00196078	0.0976355474617123
LEIGH SYNDROME	0.00196078	0.0976355474617123
MENTAL RETARDATION, X-LINKED 104; MRX104	0.00196078	0.0976355474617123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.00196078	0.0976355474617123
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00196078	0.0976355474617123
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.00196078	0.0976355474617123
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00196078	0.0976355474617123
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00196078	0.0976355474617123
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00196078	0.0976355474617123
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00196078	0.0976355474617123
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00196078	0.0976355474617123
SPINOCEREBELLAR ATAXIA 1	0.00196078	0.0976355474617123
MARSHALL-SMITH SYNDROME	0.00196078	0.0976355474617123
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00196078	0.0976355474617123
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00196078	0.0976355474617123
MECKEL SYNDROME	0.00196078	0.0976355474617123
OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS	0.00196078	0.0976355474617123
LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	0.00196078	0.0976355474617123
PHACE ASSOCIATION	0.00196078	0.0976355474617123
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00196078	0.0976355474617123
HISTIOCYTOID CARDIOMYOPATHY	0.00196078	0.0976355474617123
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00196078	0.0976355474617123
WALKER-WARBURG SYNDROME	0.00196078	0.0976355474617123
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.00196078	0.0976355474617123
CAMOS SYNDROME	0.00196078	0.0976355474617123
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00196078	0.0976355474617123
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00196078	0.0976355474617123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00196078	0.0976355474617123
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00196078	0.0976355474617123
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00196078	0.0976355474617123
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00196078	0.0976355474617123
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00196078	0.0976355474617123
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00196078	0.0976355474617123
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00196078	0.0976355474617123
SPINOCEREBELLAR ATAXIA 13	0.00196078	0.0976355474617123
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00196078	0.0976355474617123
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00196078	0.0976355474617123
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00196078	0.0976355474617123
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00196078	0.0976355474617123
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00196078	0.0976355474617123
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00196078	0.0976355474617123
CONGENITAL HYDROCEPHALUS	0.00196078	0.0976355474617123
WOLFRAM SYNDROME 2; WFS2	0.00196078	0.0976355474617123
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00196078	0.0976355474617123
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00196078	0.0976355474617123
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00196078	0.0976355474617123
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00196078	0.0976355474617123
DIENCEPHALIC SYNDROME	0.00196078	0.0976355474617123
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00196078	0.0976355474617123
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00196078	0.0976355474617123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00196078	0.0976355474617123
AICARDI SYNDROME	0.00196078	0.0976355474617123
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.00196078	0.0976355474617123
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00196078	0.0976355474617123
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00196078	0.0976355474617123
LISSENCEPHALY 8; LIS8	0.00196078	0.0976355474617123
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00196078	0.0976355474617123
IMMUNOGLOBULIN A VASCULITIS	0.00196078	0.0976355474617123
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00065189	0.03246036630056183
GENITOPATELLAR SYNDROME	0.00065189	0.03246036630056183
COXOAURICULAR SYNDROME	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00065189	0.03246036630056183
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00065189	0.03246036630056183
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00065189	0.03246036630056183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00065189	0.03246036630056183
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.03246036630056183
MARINESCO-SJOGREN SYNDROME; MSS	0.00065189	0.03246036630056183
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00065189	0.03246036630056183
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00065189	0.03246036630056183
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00065189	0.03246036630056183
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.03246036630056183
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00065189	0.03246036630056183
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00065189	0.03246036630056183
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.03246036630056183
ADRENOMYODYSTROPHY	0.00065189	0.03246036630056183
DYSSPONDYLOENCHONDROMATOSIS	0.00065189	0.03246036630056183
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.03246036630056183
SEPTOOPTIC DYSPLASIA	0.00065189	0.03246036630056183
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00065189	0.03246036630056183
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.03246036630056183
PALLISTER-HALL SYNDROME	0.00065189	0.03246036630056183
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00065189	0.03246036630056183
PFEIFFER SYNDROME	0.00065189	0.03246036630056183
TEMPLE-BARAITSER SYNDROME	0.00065189	0.03246036630056183
RIDDLE SYNDROME	0.00065189	0.03246036630056183
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.03246036630056183
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00065189	0.03246036630056183
SAY SYNDROME	0.00065189	0.03246036630056183
HYALURONIDASE DEFICIENCY	0.00065189	0.03246036630056183
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00065189	0.03246036630056183
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.03246036630056183
RUVALCABA SYNDROME	0.00065189	0.03246036630056183
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00065189	0.03246036630056183
13Q12.3 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.03246036630056183
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00065189	0.03246036630056183
MARTSOLF SYNDROME	0.00065189	0.03246036630056183
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00065189	0.03246036630056183
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00065189	0.03246036630056183
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.03246036630056183
SHPRINTZEN OMPHALOCELE SYNDROME	0.00065189	0.03246036630056183
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00065189	0.03246036630056183
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.03246036630056183
SJÖGREN-LARSSON SYNDROME	0.00065189	0.03246036630056183
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00065189	0.03246036630056183
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00065189	0.03246036630056183
SMITH-MAGENIS SYNDROME	0.00065189	0.03246036630056183
HIRSCHSPRUNG DISEASE	0.00065189	0.03246036630056183
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.03246036630056183
RABSON-MENDENHALL SYNDROME	0.00065189	0.03246036630056183
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.03246036630056183
ASPARTYLGLUCOSAMINURIA; AGU	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.03246036630056183
VELOCARDIOFACIAL SYNDROME	0.00065189	0.03246036630056183
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00065189	0.03246036630056183
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00065189	0.03246036630056183
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00065189	0.03246036630056183
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.03246036630056183
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.03246036630056183
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.03246036630056183
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.03246036630056183
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00065189	0.03246036630056183
ERMINE PHENOTYPE	0.00065189	0.03246036630056183
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00065189	0.03246036630056183
JUVENILE POLYPOSIS OF INFANCY	0.00065189	0.03246036630056183
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00065189	0.03246036630056183
EIKEN SYNDROME	0.00065189	0.03246036630056183
WILLIAMS-BEUREN SYNDROME (WBS)	0.00065189	0.03246036630056183
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.03246036630056183
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.03246036630056183
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.00065189	0.03246036630056183
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00065189	0.03246036630056183
2Q33.1 DELETION SYNDROME	0.00065189	0.03246036630056183
15Q24 RECURRENT MICRODELETION SYNDROME	0.00065189	0.03246036630056183
GORDON SYNDROME	0.00065189	0.03246036630056183
XYLT1-CDG	0.00065189	0.03246036630056183
RUBINSTEIN-TAYBI SYNDROME	0.00065189	0.03246036630056183
RETT SYNDROME	0.00065189	0.03246036630056183
MICROPHTHALMIA, SYNDROMIC 3	0.00065189	0.03246036630056183
22Q11.2 DISTAL DELETION SYNDROME	0.00065189	0.03246036630056183
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00065189	0.03246036630056183
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.03246036630056183
15Q13.3 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.00065189	0.03246036630056183
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00065189	0.03246036630056183
MCDONOUGH SYNDROME	0.00065189	0.03246036630056183
ATYPICAL WERNER SYNDROME	0.00065189	0.03246036630056183
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.03246036630056183
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.03246036630056183
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.03246036630056183
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00065189	0.03246036630056183
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.03246036630056183
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00065189	0.03246036630056183
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00065189	0.03246036630056183
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
MEND SYNDROME	0.00065189	0.03246036630056183
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.03246036630056183
SMITH-MAGENIS SYNDROME	0.00065189	0.03246036630056183
BRACHYDACTYLY, TYPE A6	0.00065189	0.03246036630056183
C SYNDROME	0.00065189	0.03246036630056183
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.03246036630056183
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00065189	0.03246036630056183
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.03246036630056183
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
ISOLATED SPINA BIFIDA	0.00065189	0.03246036630056183
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00065189	0.03246036630056183
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00065189	0.03246036630056183
SHWACHMAN-DIAMOND SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.03246036630056183
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00065189	0.03246036630056183
BIEMOND SYNDROME II	0.00065189	0.03246036630056183
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00065189	0.03246036630056183
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00065189	0.03246036630056183
MOSAIC MONOSOMY X	0.00065189	0.03246036630056183
MONOSOMY X	0.00065189	0.03246036630056183
AURICULOOSTEODYSPLASIA	0.00065189	0.03246036630056183
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.03246036630056183
THORACOPELVIC DYSOSTOSIS	0.00065189	0.03246036630056183
PRADER-WILLI SYNDROME	0.00065189	0.03246036630056183
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.03246036630056183
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.03246036630056183
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00065189	0.03246036630056183
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.03246036630056183
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00065189	0.03246036630056183
SECKEL SYNDROME	0.00065189	0.03246036630056183
OHDO SYNDROME	0.00065189	0.03246036630056183
STORMORKEN SYNDROME; STRMK	0.00065189	0.03246036630056183
STIFF SKIN SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.00065189	0.03246036630056183
THANATOPHORIC DYSPLASIA TYPE 2	0.00065189	0.03246036630056183
HYPOPHOSPHATASIA	0.00065189	0.03246036630056183
BRACHYDACTYLY TYPE E	0.00065189	0.03246036630056183
FLOATING-HARBOR SYNDROME	0.00065189	0.03246036630056183
XQ25 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.03246036630056183
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00065189	0.03246036630056183
BRADDOCK SYNDROME	0.00065189	0.03246036630056183
AICARDI-GOUTIÈRES SYNDROME	0.00065189	0.03246036630056183
BRANCHIOGENIC DEAFNESS SYNDROME	0.00065189	0.03246036630056183
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00065189	0.03246036630056183
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.03246036630056183
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00065189	0.03246036630056183
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00065189	0.03246036630056183
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.03246036630056183
LEPRECHAUNISM	0.00065189	0.03246036630056183
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
BRACHYDACTYLY TYPE A4	0.00065189	0.03246036630056183
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00065189	0.03246036630056183
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.03246036630056183
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.03246036630056183
FOUNTAIN SYNDROME	0.00065189	0.03246036630056183
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00065189	0.03246036630056183
X-LINKED AGAMMAGLOBULINEMIA	0.00065189	0.03246036630056183
SMITH-FINEMAN-MYERS SYNDROME	0.00065189	0.03246036630056183
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.03246036630056183
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.03246036630056183
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00065189	0.03246036630056183
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.03246036630056183
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.03246036630056183
CARPENTER-WAZIRI SYNDROME	0.00065189	0.03246036630056183
JUBERG-MARSIDI SYNDROME	0.00065189	0.03246036630056183
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00065189	0.03246036630056183
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.03246036630056183
JEUNE SYNDROME	0.00065189	0.03246036630056183
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.03246036630056183
HOLMES-GANG SYNDROME	0.00065189	0.03246036630056183
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00065189	0.03246036630056183
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00065189	0.03246036630056183
BRACHYDACTYLY TYPE A1	0.00065189	0.03246036630056183
BRACHYDACTYLY TYPE C	0.00065189	0.03246036630056183
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00065189	0.03246036630056183
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00065189	0.03246036630056183
KABUKI SYNDROME 1	0.00065189	0.03246036630056183
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.03246036630056183
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00065189	0.03246036630056183
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.03246036630056183
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.03246036630056183
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.03246036630056183
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.03246036630056183
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.03246036630056183
CHROMOSOME 18P DELETION SYNDROME	0.00065189	0.03246036630056183
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00065189	0.03246036630056183
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00065189	0.03246036630056183
PALLISTER-HALL SYNDROME	0.00065189	0.03246036630056183
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.03246036630056183
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.00065189	0.03246036630056183
HARTNUP DISORDER	0.00065189	0.03246036630056183
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE IB	0.00065189	0.03246036630056183
PELVISCAPULAR DYSPLASIA	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.03246036630056183
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00065189	0.03246036630056183
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.03246036630056183
KBG SYNDROME	0.00065189	0.03246036630056183
AROMATASE EXCESS SYNDROME	0.00065189	0.03246036630056183
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.03246036630056183
HAIRY ELBOWS	0.00065189	0.03246036630056183
ABRUZZO-ERICKSON SYNDROME	0.00065189	0.03246036630056183
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00065189	0.03246036630056183
HOLOPROSENCEPHALY 1; HPE1	0.00065189	0.03246036630056183
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00065189	0.03246036630056183
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00065189	0.03246036630056183
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.03246036630056183
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE IA	0.00065189	0.03246036630056183
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
15Q24 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.03246036630056183
CROME SYNDROME	0.00065189	0.03246036630056183
PRADER-WILLI SYNDROME; PWS	0.00065189	0.03246036630056183
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00065189	0.03246036630056183
DISTAL TRISOMY 5Q	0.00065189	0.03246036630056183
MOSAIC TRISOMY 8	0.00065189	0.03246036630056183
245800 LAURENCE-MOON SYNDROME	0.00065189	0.03246036630056183
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.03246036630056183
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00065189	0.03246036630056183
THYROID HYPOPLASIA	0.00065189	0.03246036630056183
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00065189	0.03246036630056183
MULTIMINICORE MYOPATHY	0.00065189	0.03246036630056183
JOHANSON-BLIZZARD SYNDROME; JBS	0.00065189	0.03246036630056183
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.03246036630056183
TURNER SYNDROME	0.00065189	0.03246036630056183
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00065189	0.03246036630056183
FAMILIAL THYROID DYSHORMONOGENESIS	0.00065189	0.03246036630056183
TETRASOMY 12P	0.00065189	0.03246036630056183
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.03246036630056183
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.03246036630056183
ACROCAPITOFEMORAL DYSPLASIA	0.00065189	0.03246036630056183
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00065189	0.03246036630056183
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00065189	0.03246036630056183
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.03246036630056183
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00065189	0.03246036630056183
KOOLEN-DE VRIES SYNDROME	0.00065189	0.03246036630056183
RADIAL-RENAL SYNDROME	0.00065189	0.03246036630056183
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00065189	0.03246036630056183
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00065189	0.03246036630056183
DISTAL MONOSOMY 12Q	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC RICKETS	0.00065189	0.03246036630056183
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00065189	0.03246036630056183
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.00065189	0.03246036630056183
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.03246036630056183
ATHYREOSIS	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00065189	0.03246036630056183
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00065189	0.03246036630056183
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.00065189	0.03246036630056183
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.03246036630056183
NEUROFIBROMATOSIS, TYPE I	0.00065189	0.03246036630056183
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00065189	0.03246036630056183
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.03246036630056183
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.03246036630056183
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.03246036630056183
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00065189	0.03246036630056183
NAIL-PATELLA SYNDROME	0.00065189	0.03246036630056183
FANCONI ANEMIA	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.03246036630056183
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00065189	0.03246036630056183
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.03246036630056183
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00065189	0.03246036630056183
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00065189	0.03246036630056183
THYROID ECTOPIA	0.00065189	0.03246036630056183
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.03246036630056183
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.03246036630056183
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00065189	0.03246036630056183
X-LINKED HYPOPHOSPHATEMIA	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00065189	0.03246036630056183
PITUITARY STALK INTERRUPTION SYNDROME	0.00065189	0.03246036630056183
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00065189	0.03246036630056183
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00065189	0.03246036630056183
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00065189	0.03246036630056183
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00065189	0.03246036630056183
LATERAL MENINGOCELE SYNDROME	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.03246036630056183
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.03246036630056183
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.03246036630056183
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.03246036630056183
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00065189	0.03246036630056183
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.03246036630056183
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.03246036630056183
NOONAN SYNDROME 2; NS2	0.00065189	0.03246036630056183
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00065189	0.03246036630056183
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00065189	0.03246036630056183
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00065189	0.03246036630056183
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00065189	0.03246036630056183
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00065189	0.03246036630056183
POPOV-CHANG SYNDROME; POPCHAS	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00065189	0.03246036630056183
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00065189	0.03246036630056183
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.03246036630056183
PROPIONIC ACIDEMIA	0.00065189	0.03246036630056183
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00065189	0.03246036630056183
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00065189	0.03246036630056183
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.03246036630056183
SAUL-WILSON SYNDROME; SWILS	0.00065189	0.03246036630056183
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00065189	0.03246036630056183
BARTTER SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.03246036630056183
BARDET-BIEDL SYNDROME	0.00065189	0.03246036630056183
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.03246036630056183
METAPHYSEAL ANADYSPLASIA	0.00065189	0.03246036630056183
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00065189	0.03246036630056183
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00065189	0.03246036630056183
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.03246036630056183
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00065189	0.03246036630056183
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00065189	0.03246036630056183
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.03246036630056183
2Q37 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
ATAXIA-TELANGIECTASIA	0.00065189	0.03246036630056183
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.03246036630056183
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00065189	0.03246036630056183
MICROHYDRANENCEPHALY; MHAC	0.00065189	0.03246036630056183
NOONAN SYNDROME 11; NS11	0.00065189	0.03246036630056183
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00065189	0.03246036630056183
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00065189	0.03246036630056183
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.03246036630056183
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00065189	0.03246036630056183
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00065189	0.03246036630056183
COFFIN-SIRIS SYNDROME 6; CSS6	0.00065189	0.03246036630056183
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00065189	0.03246036630056183
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00065189	0.03246036630056183
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00065189	0.03246036630056183
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00065189	0.03246036630056183
AL KAISSI SYNDROME; ALKAS	0.00065189	0.03246036630056183
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.03246036630056183
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00065189	0.03246036630056183
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00065189	0.03246036630056183
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.03246036630056183
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00065189	0.03246036630056183
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00065189	0.03246036630056183
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00065189	0.03246036630056183
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00065189	0.03246036630056183
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00065189	0.03246036630056183
IMMUNODEFICIENCY 55; IMD55	0.00065189	0.03246036630056183
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00065189	0.03246036630056183
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00065189	0.03246036630056183
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00065189	0.03246036630056183
COFFIN-SIRIS SYNDROME 7; CSS7	0.00065189	0.03246036630056183
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00065189	0.03246036630056183
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00065189	0.03246036630056183
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00065189	0.03246036630056183
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.03246036630056183
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00065189	0.03246036630056183
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00065189	0.03246036630056183
CHROMOSOME 1P35 DELETION SYNDROME	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME XVII	0.00065189	0.03246036630056183
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00065189	0.03246036630056183
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.03246036630056183
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.03246036630056183
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00065189	0.03246036630056183
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.03246036630056183
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.03246036630056183
AYME-GRIPP SYNDROME; AYGRP	0.00065189	0.03246036630056183
CODAS SYNDROME	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00065189	0.03246036630056183
CLEIDOCRANIAL DYSPLASIA	0.00065189	0.03246036630056183
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.03246036630056183
RING CHROMOSOME 7 SYNDROME	0.00065189	0.03246036630056183
RING CHROMOSOME 6 SYNDROME	0.00065189	0.03246036630056183
GURRIERI SYNDROME	0.00065189	0.03246036630056183
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.03246036630056183
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00065189	0.03246036630056183
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00065189	0.03246036630056183
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.03246036630056183
BIEMOND SYNDROME TYPE 2	0.00065189	0.03246036630056183
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.03246036630056183
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.03246036630056183
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00065189	0.03246036630056183
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.03246036630056183
CAMPOMELIC DYSPLASIA	0.00065189	0.03246036630056183
COFFIN-SIRIS SYNDROME	0.00065189	0.03246036630056183
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.03246036630056183
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00065189	0.03246036630056183
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00065189	0.03246036630056183
MONOSOMY 18P	0.00065189	0.03246036630056183
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00065189	0.03246036630056183
DISTAL MONOSOMY 15Q	0.00065189	0.03246036630056183
MONOSOMY 13Q14	0.00065189	0.03246036630056183
CHROMOSOME 2Q37 DELETION SYNDROME	0.00065189	0.03246036630056183
DISTAL MONOSOMY 10P	0.00065189	0.03246036630056183
ANE SYNDROME	0.00065189	0.03246036630056183
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.03246036630056183
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.03246036630056183
SATOYOSHI SYNDROME	0.00065189	0.03246036630056183
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00065189	0.03246036630056183
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.03246036630056183
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.03246036630056183
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.03246036630056183
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
COXOAURICULAR SYNDROME	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00065189	0.03246036630056183
KENNERKNECHT SYNDROME	0.00065189	0.03246036630056183
COOPER-JABS SYNDROME	0.00065189	0.03246036630056183
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.03246036630056183
17Q11.2 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
CEREBROFACIOTHORACIC DYSPLASIA	0.00065189	0.03246036630056183
CEREBROCOSTOMANDIBULAR SYNDROME	0.00065189	0.03246036630056183
ATKIN-FLAITZ SYNDROME	0.00065189	0.03246036630056183
BLOOM SYNDROME	0.00065189	0.03246036630056183
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.03246036630056183
BLACKFAN-DIAMOND ANEMIA	0.00065189	0.03246036630056183
RHYNS SYNDROME; RHYNS	0.00065189	0.03246036630056183
BALLER-GEROLD SYNDROME	0.00065189	0.03246036630056183
PIERPONT SYNDROME	0.00065189	0.03246036630056183
LARYNX ATRESIA	0.00065189	0.03246036630056183
ATRESIA OF SMALL INTESTINE	0.00065189	0.03246036630056183
GRACILE BONE DYSPLASIA; GCLEB	0.00065189	0.03246036630056183
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00065189	0.03246036630056183
CATEL-MANZKE SYNDROME	0.00065189	0.03246036630056183
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00065189	0.03246036630056183
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.03246036630056183
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00065189	0.03246036630056183
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00065189	0.03246036630056183
SHELDON-HALL SYNDROME	0.00065189	0.03246036630056183
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.03246036630056183
AURICULOOSTEODYSPLASIA	0.00065189	0.03246036630056183
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.03246036630056183
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00065189	0.03246036630056183
BOWEN-CONRADI SYNDROME	0.00065189	0.03246036630056183
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.03246036630056183
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00065189	0.03246036630056183
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00065189	0.03246036630056183
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.03246036630056183
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00065189	0.03246036630056183
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00065189	0.03246036630056183
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.03246036630056183
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00065189	0.03246036630056183
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.03246036630056183
CAREY-FINEMAN-ZITER SYNDROME	0.00065189	0.03246036630056183
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.03246036630056183
STUVE-WIEDEMANN SYNDROME	0.00065189	0.03246036630056183
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00065189	0.03246036630056183
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00065189	0.03246036630056183
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.03246036630056183
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00065189	0.03246036630056183
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00065189	0.03246036630056183
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00065189	0.03246036630056183
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.03246036630056183
BRANCHIO-OCULO-FACIAL SYNDROME	0.00065189	0.03246036630056183
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00065189	0.03246036630056183
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00065189	0.03246036630056183
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00065189	0.03246036630056183
CHROMOSOME 17Q12 DELETION SYNDROME	0.00065189	0.03246036630056183
CORNELIA DE LANGE SYNDROME 3	0.00065189	0.03246036630056183
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00065189	0.03246036630056183
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.03246036630056183
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.03246036630056183
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00065189	0.03246036630056183
CHROMOSOME 15Q25 DELETION SYNDROME	0.00065189	0.03246036630056183
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.03246036630056183
PERRAULT SYNDROME 3	0.00065189	0.03246036630056183
NOONAN SYNDROME 4; NS4	0.00065189	0.03246036630056183
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00065189	0.03246036630056183
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.03246036630056183
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00065189	0.03246036630056183
NOONAN SYNDROME 5; NS5	0.00065189	0.03246036630056183
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00065189	0.03246036630056183
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00065189	0.03246036630056183
LISSENCEPHALY 4	0.00065189	0.03246036630056183
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00065189	0.03246036630056183
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.03246036630056183
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.03246036630056183
LOEYS-DIETZ SYNDROME 5	0.00065189	0.03246036630056183
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00065189	0.03246036630056183
SCHAAF-YANG SYNDROME; SHFYNG	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00065189	0.03246036630056183
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00065189	0.03246036630056183
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00065189	0.03246036630056183
NOONAN SYNDROME 8; NS8	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00065189	0.03246036630056183
STEEL SYNDROME; STLS	0.00065189	0.03246036630056183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00065189	0.03246036630056183
KOOLEN-DE VRIES SYNDROME; KDVS	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00065189	0.03246036630056183
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.03246036630056183
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00065189	0.03246036630056183
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.03246036630056183
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00065189	0.03246036630056183
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00065189	0.03246036630056183
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00065189	0.03246036630056183
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.03246036630056183
GLASS SYNDROME	0.00065189	0.03246036630056183
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 10	0.00065189	0.03246036630056183
NOONAN SYNDROME 6; NS6	0.00065189	0.03246036630056183
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.03246036630056183
MACS SYNDROME	0.00065189	0.03246036630056183
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.03246036630056183
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00065189	0.03246036630056183
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00065189	0.03246036630056183
HADZISELIMOVIC SYNDROME	0.00065189	0.03246036630056183
THREE M SYNDROME 2; 3M2	0.00065189	0.03246036630056183
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.03246036630056183
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.03246036630056183
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 5	0.00065189	0.03246036630056183
DIAMOND-BLACKFAN ANEMIA 4	0.00065189	0.03246036630056183
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.03246036630056183
FONTAINE PROGEROID SYNDROME; FPS	0.00065189	0.03246036630056183
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00065189	0.03246036630056183
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE X	0.00065189	0.03246036630056183
SECKEL SYNDROME 5; SCKL5	0.00065189	0.03246036630056183
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.03246036630056183
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00065189	0.03246036630056183
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00065189	0.03246036630056183
NOONAN SYNDROME 7; NS7	0.00065189	0.03246036630056183
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.03246036630056183
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.03246036630056183
SECKEL SYNDROME 4	0.00065189	0.03246036630056183
HUNTER-MACDONALD SYNDROME	0.00065189	0.03246036630056183
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00065189	0.03246036630056183
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.03246036630056183
FORSYTHE-WAKELING SYNDROME; FWS	0.00065189	0.03246036630056183
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00065189	0.03246036630056183
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00065189	0.03246036630056183
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00065189	0.03246036630056183
NOONAN SYNDROME 3; NS3	0.00065189	0.03246036630056183
SECKEL SYNDROME 8; SCKL8	0.00065189	0.03246036630056183
JOUBERT SYNDROME 26	0.00065189	0.03246036630056183
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00065189	0.03246036630056183
COFFIN-SIRIS SYNDROME 5	0.00065189	0.03246036630056183
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00065189	0.03246036630056183
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00065189	0.03246036630056183
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00065189	0.03246036630056183
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00065189	0.03246036630056183
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00065189	0.03246036630056183
LUSCAN-LUMISH SYNDROME; LLS	0.00065189	0.03246036630056183
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00065189	0.03246036630056183
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00065189	0.03246036630056183
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.03246036630056183
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00065189	0.03246036630056183
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00065189	0.03246036630056183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00065189	0.03246036630056183
LARSEN-LIKE SYNDROME	0.00065189	0.03246036630056183
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.03246036630056183
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00065189	0.03246036630056183
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.03246036630056183
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.03246036630056183
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00065189	0.03246036630056183
MIRAGE SYNDROME; MIRAGE	0.00065189	0.03246036630056183
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.03246036630056183
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.03246036630056183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00065189	0.03246036630056183
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00065189	0.03246036630056183
DYSTONIA 28, CHILDHOOD-ONSET	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00065189	0.03246036630056183
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00065189	0.03246036630056183
CHITAYAT SYNDROME	0.00065189	0.03246036630056183
SIFRIM-HITZ-WEISS SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00065189	0.03246036630056183
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00065189	0.03246036630056183
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00065189	0.03246036630056183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.03246036630056183
ALAZAMI-YUAN SYNDROME	0.00065189	0.03246036630056183
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.03246036630056183
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00065189	0.03246036630056183
MEIER-GORLIN SYNDROME 7	0.00065189	0.03246036630056183
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00065189	0.03246036630056183
NOONAN SYNDROME 10; NS10	0.00065189	0.03246036630056183
NOONAN SYNDROME 9; NS9	0.00065189	0.03246036630056183
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00065189	0.03246036630056183
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00065189	0.03246036630056183
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.03246036630056183
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.03246036630056183
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00065189	0.03246036630056183
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00065189	0.03246036630056183
CHROMOSOME 10Q26 DELETION SYNDROME	0.00065189	0.03246036630056183
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00065189	0.03246036630056183
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.03246036630056183
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.03246036630056183
FRIAS SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00065189	0.03246036630056183
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.03246036630056183
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.03246036630056183
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00065189	0.03246036630056183
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.03246036630056183
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00065189	0.03246036630056183
CULLER-JONES SYNDROME; CJS	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00065189	0.03246036630056183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00065189	0.03246036630056183
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00065189	0.03246036630056183
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00065189	0.03246036630056183
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.03246036630056183
CEREBELLOFACIODENTAL SYNDROME	0.00065189	0.03246036630056183
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.03246036630056183
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00065189	0.03246036630056183
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.03246036630056183
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00065189	0.03246036630056183
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00065189	0.03246036630056183
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00065189	0.03246036630056183
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.03246036630056183
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00065189	0.03246036630056183
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00065189	0.03246036630056183
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.03246036630056183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00065189	0.03246036630056183
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.03246036630056183
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.03246036630056183
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.03246036630056183
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.03246036630056183
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00065189	0.03246036630056183
BRUCK SYNDROME 2	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00065189	0.03246036630056183
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.03246036630056183
MONOSOMY 18Q	0.00065189	0.03246036630056183
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00065189	0.03246036630056183
DISTAL MONOSOMY 3P	0.00065189	0.03246036630056183
PARANA HARD SKIN SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.03246036630056183
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
SJOGREN-LARSSON SYNDROME; SLS	0.00065189	0.03246036630056183
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00065189	0.03246036630056183
XP22.13P22.2 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00065189	0.03246036630056183
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00065189	0.03246036630056183
SONODA SYNDROME	0.00065189	0.03246036630056183
STIFF SKIN SYNDROME	0.00065189	0.03246036630056183
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.00065189	0.03246036630056183
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.03246036630056183
MONOSOMY 5P	0.00065189	0.03246036630056183
OTOFACIOCERVICAL SYNDROME	0.00065189	0.03246036630056183
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.03246036630056183
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.03246036630056183
BRUCK SYNDROME	0.00065189	0.03246036630056183
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00065189	0.03246036630056183
OSLAM SYNDROME	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME TYPE 6	0.00065189	0.03246036630056183
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.03246036630056183
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.03246036630056183
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.03246036630056183
LEUKOCYTE ADHESION DEFICIENCY	0.00065189	0.03246036630056183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00065189	0.03246036630056183
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.03246036630056183
RAMON SYNDROME	0.00065189	0.03246036630056183
RAPADILINO SYNDROME	0.00065189	0.03246036630056183
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00065189	0.03246036630056183
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00065189	0.03246036630056183
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00065189	0.03246036630056183
ROTHMUND-THOMSON SYNDROME	0.00065189	0.03246036630056183
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00065189	0.03246036630056183
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.03246036630056183
SACCHAROPINURIA	0.00065189	0.03246036630056183
NEURALGIC AMYOTROPHY	0.00065189	0.03246036630056183
MICROTRIPLICATION 11Q24.1	0.00065189	0.03246036630056183
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.03246036630056183
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.03246036630056183
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00065189	0.03246036630056183
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.03246036630056183
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME TYPE 2	0.00065189	0.03246036630056183
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00065189	0.03246036630056183
TEEBI-SHALTOUT SYNDROME; TBSH	0.00065189	0.03246036630056183
DENT DISEASE 1	0.00065189	0.03246036630056183
16P11.2P12.2 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
15Q14 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.03246036630056183
WERNER SYNDROME; WRN	0.00065189	0.03246036630056183
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00065189	0.03246036630056183
MULIBREY NANISM	0.00065189	0.03246036630056183
MOYNAHAN SYNDROME	0.00065189	0.03246036630056183
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00065189	0.03246036630056183
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00065189	0.03246036630056183
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00065189	0.03246036630056183
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00065189	0.03246036630056183
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00065189	0.03246036630056183
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00065189	0.03246036630056183
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00065189	0.03246036630056183
LESCH-NYHAN SYNDROME; LNS	0.00065189	0.03246036630056183
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00065189	0.03246036630056183
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00065189	0.03246036630056183
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00065189	0.03246036630056183
16P13.11 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
17Q12 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
TRISOMY 17P	0.00065189	0.03246036630056183
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00065189	0.03246036630056183
NEUROFACIODIGITORENAL SYNDROME	0.00065189	0.03246036630056183
NATHALIE SYNDROME	0.00065189	0.03246036630056183
KEIPERT SYNDROME	0.00065189	0.03246036630056183
14Q22Q23 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.03246036630056183
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME VI	0.00065189	0.03246036630056183
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00065189	0.03246036630056183
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.03246036630056183
3M SYNDROME	0.00065189	0.03246036630056183
RING CHROMOSOME Y SYNDROME	0.00065189	0.03246036630056183
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.03246036630056183
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.03246036630056183
KLEEFSTRA SYNDROME	0.00065189	0.03246036630056183
XQ27.3Q28 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.03246036630056183
20P12.3 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
ACROOTOOCULAR SYNDROME	0.00065189	0.03246036630056183
PSEUDOPROGERIA SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00065189	0.03246036630056183
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.03246036630056183
URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.03246036630056183
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00065189	0.03246036630056183
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.03246036630056183
TRISOMY 18	0.00065189	0.03246036630056183
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00065189	0.03246036630056183
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.03246036630056183
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.03246036630056183
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.03246036630056183
HOYERAAL-HREIDARSSON SYNDROME	0.00065189	0.03246036630056183
THALIDOMIDE EMBRYOPATHY	0.00065189	0.03246036630056183
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.03246036630056183
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.03246036630056183
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME IV; OFD4	0.00065189	0.03246036630056183
9P13 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME IX; OFD9	0.00065189	0.03246036630056183
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00065189	0.03246036630056183
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.03246036630056183
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.03246036630056183
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.03246036630056183
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.03246036630056183
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.03246036630056183
DISTAL MONOSOMY 1Q	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00065189	0.03246036630056183
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00065189	0.03246036630056183
MUCOLIPIDOSIS III ALPHA/BETA	0.00065189	0.03246036630056183
ROIFMAN SYNDROME	0.00065189	0.03246036630056183
MUCOLIPIDOSIS III GAMMA	0.00065189	0.03246036630056183
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00065189	0.03246036630056183
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.03246036630056183
YUNIS-VARON SYNDROME	0.00065189	0.03246036630056183
WILSON-TURNER SYNDROME	0.00065189	0.03246036630056183
MULTIPLE OSTEOCHONDROMAS	0.00065189	0.03246036630056183
PRIMROSE SYNDROME; PRIMS	0.00065189	0.03246036630056183
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00065189	0.03246036630056183
COSTELLO SYNDROME	0.00065189	0.03246036630056183
LAMELLAR ICHTHYOSIS	0.00065189	0.03246036630056183
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.03246036630056183
OXOGLUTARIC ACIDURIA	0.00065189	0.03246036630056183
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.03246036630056183
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.03246036630056183
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00065189	0.03246036630056183
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00065189	0.03246036630056183
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.03246036630056183
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00065189	0.03246036630056183
DDOST-CDG	0.00065189	0.03246036630056183
SAGLIKER SYNDROME	0.00065189	0.03246036630056183
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.03246036630056183
PYGMY	0.00065189	0.03246036630056183
SATOYOSHI SYNDROME	0.00065189	0.03246036630056183
ULNAR-MAMMARY SYNDROME	0.00065189	0.03246036630056183
XQ12-Q13.3 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00065189	0.03246036630056183
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00065189	0.03246036630056183
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.03246036630056183
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.03246036630056183
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.03246036630056183
STIMMLER SYNDROME	0.00065189	0.03246036630056183
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00065189	0.03246036630056183
RAINE SYNDROME	0.00065189	0.03246036630056183
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.03246036630056183
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
ERYTHROKERATODERMIA VARIABILIS	0.00065189	0.03246036630056183
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.03246036630056183
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.03246036630056183
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.03246036630056183
SHOX-RELATED SHORT STATURE	0.00065189	0.03246036630056183
CEREBROFACIOARTICULAR SYNDROME	0.00065189	0.03246036630056183
DUPLICATION OF THE PITUITARY GLAND	0.00065189	0.03246036630056183
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00065189	0.03246036630056183
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00065189	0.03246036630056183
CODAS SYNDROME	0.00065189	0.03246036630056183
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.03246036630056183
EPILEPSY-TELANGIECTASIA SYNDROME	0.00065189	0.03246036630056183
CAT-EYE SYNDROME	0.00065189	0.03246036630056183
CRANIOFRONTONASAL SYNDROME; CFNS	0.00065189	0.03246036630056183
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.03246036630056183
ENG-STROM SYNDROME	0.00065189	0.03246036630056183
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00065189	0.03246036630056183
TOLUENE EMBRYOPATHY	0.00065189	0.03246036630056183
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.03246036630056183
EEC SYNDROME	0.00065189	0.03246036630056183
HIDROTIC ECTODERMAL DYSPLASIA	0.00065189	0.03246036630056183
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00065189	0.03246036630056183
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.03246036630056183
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.03246036630056183
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00065189	0.03246036630056183
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00065189	0.03246036630056183
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00065189	0.03246036630056183
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00065189	0.03246036630056183
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.03246036630056183
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.03246036630056183
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00065189	0.03246036630056183
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00065189	0.03246036630056183
8P23.1 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
CUTIS LAXA	0.00065189	0.03246036630056183
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00065189	0.03246036630056183
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
GERMAN SYNDROME	0.00065189	0.03246036630056183
GEMIGNANI SYNDROME	0.00065189	0.03246036630056183
CHARGE-LIKE SYNDROME, X-LINKED	0.00065189	0.03246036630056183
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00065189	0.03246036630056183
MASA SYNDROME	0.00065189	0.03246036630056183
FRYNS-SMEETS-THIRY SYNDROME	0.00065189	0.03246036630056183
FREEMAN-SHELDON SYNDROME	0.00065189	0.03246036630056183
FEMORAL-FACIAL SYNDROME	0.00065189	0.03246036630056183
COLE-CARPENTER SYNDROME	0.00065189	0.03246036630056183
FLOATING-HARBOR SYNDROME	0.00065189	0.03246036630056183
FIBROCHONDROGENESIS	0.00065189	0.03246036630056183
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00065189	0.03246036630056183
COFFIN-LOWRY SYNDROME; CLS	0.00065189	0.03246036630056183
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.03246036630056183
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.03246036630056183
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00065189	0.03246036630056183
COWDEN SYNDROME	0.00065189	0.03246036630056183
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.03246036630056183
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00065189	0.03246036630056183
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.03246036630056183
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.03246036630056183
TRISOMY 12P	0.00065189	0.03246036630056183
NON-DISTAL TRISOMY 10Q	0.00065189	0.03246036630056183
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00065189	0.03246036630056183
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.00065189	0.03246036630056183
NATIVE AMERICAN MYOPATHY	0.00065189	0.03246036630056183
H SYNDROME	0.00065189	0.03246036630056183
WIEACKER-WOLFF SYNDROME	0.00065189	0.03246036630056183
KEARNS-SAYRE SYNDROME; KSS	0.00065189	0.03246036630056183
WOLCOTT-RALLISON SYNDROME	0.00065189	0.03246036630056183
ODONTOCHONDRODYSPLASIA	0.00065189	0.03246036630056183
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00065189	0.03246036630056183
EIKEN SYNDROME	0.00065189	0.03246036630056183
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.03246036630056183
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.03246036630056183
XP22.3 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.03246036630056183
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00065189	0.03246036630056183
MAFFUCCI SYNDROME	0.00065189	0.03246036630056183
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.03246036630056183
DISTAL TRISOMY 14Q	0.00065189	0.03246036630056183
17P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
SPASTIC PARAPARESIS AND DEAFNESS	0.00065189	0.03246036630056183
TRISOMY 18P	0.00065189	0.03246036630056183
MENKES DISEASE	0.00065189	0.03246036630056183
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00065189	0.03246036630056183
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00065189	0.03246036630056183
DYSOSTOSIS, STANESCU TYPE	0.00065189	0.03246036630056183
PERIPHERAL DYSOSTOSIS	0.00065189	0.03246036630056183
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00065189	0.03246036630056183
FRONTOFACIONASAL DYSPLASIA	0.00065189	0.03246036630056183
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.03246036630056183
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.03246036630056183
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00065189	0.03246036630056183
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.03246036630056183
TRISOMY XQ28	0.00065189	0.03246036630056183
DISTAL TRISOMY 6P	0.00065189	0.03246036630056183
TRISOMY 5P	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME I; OFD1	0.00065189	0.03246036630056183
TRISOMY 4P	0.00065189	0.03246036630056183
RETT SYNDROME; RTT	0.00065189	0.03246036630056183
6Q16 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
GRANT SYNDROME	0.00065189	0.03246036630056183
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00065189	0.03246036630056183
HALL-RIGGS SYNDROME	0.00065189	0.03246036630056183
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00065189	0.03246036630056183
MCDONOUGH SYNDROME	0.00065189	0.03246036630056183
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00065189	0.03246036630056183
MASA SYNDROME	0.00065189	0.03246036630056183
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00065189	0.03246036630056183
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
46,XX GONADAL DYSGENESIS	0.00065189	0.03246036630056183
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.03246036630056183
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00065189	0.03246036630056183
1Q44 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.03246036630056183
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.03246036630056183
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.03246036630056183
15Q11Q13 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.03246036630056183
LAURENCE-MOON SYNDROME	0.00065189	0.03246036630056183
CONGENITAL LARYNGEAL WEB	0.00065189	0.03246036630056183
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00065189	0.03246036630056183
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00065189	0.03246036630056183
MCKUSICK-KAUFMAN SYNDROME	0.00065189	0.03246036630056183
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.03246036630056183
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.03246036630056183
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 2	0.00065189	0.03246036630056183
2Q32Q33 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
2Q31.1 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.03246036630056183
ATKIN-FLAITZ SYNDROME	0.00065189	0.03246036630056183
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00065189	0.03246036630056183
1Q41Q42 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
1Q21.1 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00065189	0.03246036630056183
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00065189	0.03246036630056183
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.03246036630056183
ACROGERIA	0.00065189	0.03246036630056183
FRONTONASAL DYSPLASIA	0.00065189	0.03246036630056183
MESOMELIA-SYNOSTOSES SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.03246036630056183
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00065189	0.03246036630056183
MELNICK-NEEDLES SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00065189	0.03246036630056183
KBG SYNDROME	0.00065189	0.03246036630056183
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00065189	0.03246036630056183
HARTNUP DISEASE	0.00065189	0.03246036630056183
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00065189	0.03246036630056183
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00065189	0.03246036630056183
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00065189	0.03246036630056183
XQ25 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00065189	0.03246036630056183
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00065189	0.03246036630056183
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.03246036630056183
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.03246036630056183
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.03246036630056183
NEPHROGENIC DIABETES INSIPIDUS	0.00065189	0.03246036630056183
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00065189	0.03246036630056183
SANJAD-SAKATI SYNDROME	0.00065189	0.03246036630056183
PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.03246036630056183
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.03246036630056183
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.03246036630056183
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00065189	0.03246036630056183
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.03246036630056183
MOWAT-WILSON SYNDROME	0.00065189	0.03246036630056183
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00065189	0.03246036630056183
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00065189	0.03246036630056183
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00065189	0.03246036630056183
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00065189	0.03246036630056183
ICF SYNDROME	0.00065189	0.03246036630056183
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00065189	0.03246036630056183
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00065189	0.03246036630056183
KABUKI SYNDROME	0.00065189	0.03246036630056183
OGDEN SYNDROME; OGDNS	0.00065189	0.03246036630056183
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.03246036630056183
JOHANSON-BLIZZARD SYNDROME	0.00065189	0.03246036630056183
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.00065189	0.03246036630056183
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00065189	0.03246036630056183
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 99	0.00065189	0.03246036630056183
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.03246036630056183
MEND SYNDROME; MEND	0.00065189	0.03246036630056183
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00065189	0.03246036630056183
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00065189	0.03246036630056183
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.03246036630056183
ARGININOSUCCINIC ACIDURIA	0.00065189	0.03246036630056183
ISOLATED AGAMMAGLOBULINEMIA	0.00065189	0.03246036630056183
5Q35 MICRODUPLICATION SYNDROME	0.00065189	0.03246036630056183
POLYVALVULAR HEART DISEASE SYNDROME	0.00065189	0.03246036630056183
2Q23.1 MICRODELETION SYNDROME	0.00065189	0.03246036630056183
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00065189	0.03246036630056183
